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Abstract 
Biopharmaceutical production of protein for therapeutic use is an expanding practice for 
treatment of numerous diseases in medicine. However the full benefits of this technique 
have not yet been fully realised due to a number of barriers. The largest of these barriers 
is that of protein aggregation, where mis-folded protein monomers self associate to form 
non functional macromolecules; aggregates. Further understanding of protein 
aggregation may lead to an improvement in the effectiveness and availability of these 
therapeutic treatments. Here is presented work which utilises novel or under-used 
techniques to elucidate information on the structure of protein aggregates, their 
formation mechanisms and the kinetics and thermodynamics of their growth. 
Results presented in the chapter on aggregate nucleation indicate that the nucleation 
stage of aggregation in bovine serum albumin has a temperature dependant mechanism, 
which in the middle of the temperature range follow mechanisms for stable nuclei 
population postulated in the literature. However at the extremes of this range, it appears 
that the nucleation mechanisms deviate from this and that there may be clustering of 
highly reactive nuclei at high temperatures, and continual formation of aggregate nuclei 
at low temperatures. Possible explanations for this behaviour are discussed. 
Analysis presented on the growth of particulate aggregates show that the model of 
monomer addition to the aggregate nuclei appears to be a fitting description of the 
growth process, which is generic across proteins. Furthermore the detailed analysis from 
an ultra violet light scattering spectroscopy technique provides a numerical method for 
examining the efficiency of aggregate preventing additives, and also illustrates the 
mechanism by which the additives prevent aggregation through stabilising the native 
state. 
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Finally; results presented in the chapter on aggregation during refolding indicate the use 
of fluorescence anisotropy to monitor the molten globule state during refolding of 
proteins. Most strikingly, it is shown there is an obvious relationship between the 
mobility period of the protein and its propensity to aggregate. It is also shown that the 
presence of salt and urea can be utilised to moderate the presence of the molten globule 
state, and therefore the resultant aggregation. 
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Chapter 1 : Introduction 
Biopharmaceutical production of protein for therapeutic use is an expanding practice for 
treatment of numerous diseases in medicine. Such methods are common in the treatment 
of diabetes; where recombinant insulin is used for treatment. However the full benefits 
of this technique have not yet been fully realised in areas such as monoclonal antibody, 
and vaccine antigen production, as there are a number of barriers present to commercial 
production. The largest of these barriers is that of protein aggregation, where mis-folded 
protein monomers self associate to form non functional macromolecules; aggregates. 
The presence of these aggregates not only represents a loss of yield (and the cost and 
further processing in removing them), but their presence in therapeutics can trigger an 
immunogenetic response; producing anti-drug antibodies which break down the drug 
and render the treatment ineffective. Further understanding of protein aggregation may 
lead to an improvement in the effectiveness and availability of these therapeutic 
treatments. 
The current literature regarding protein aggregation describes a number of different 
aggregate morphologies and their structures; it also postulates multiple mechanisms for 
their creation and propagation. However, the literature on protein aggregation is not 
complete, and a number of areas merit further investigation including some structural 
aspects of proteins including kinetics and thermodynamics of the aggregation systems. 
This body of work utilises novel or under-used techniques to elucidate information on 
the structure of protein aggregates, their formation mechanisms and the kinetics and 
thermodynamics of their growth. The information provided by these techniques are 
compared and contrasted with more frequently used techniques in order to validate the 
conclusions made.  
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Separate chapters focus on the class of aggregate with a spherical morphology; the 
particulate aggregate, where two aspects of its formation are examined. The nucleation 
of particulate aggregates is examined using small angle neutron scattering to probe the 
system on a nanometer scale and to understand the mechanisms of its formation and its 
temperature dependant nature. Complementing this, a second chapter details the growth 
of these nuclei using ultra violet light scattering spectroscopy, which can be used to give 
numerical values regarding the kinetics and thermodynamics of the aggregate growth. 
Providing numerical values for aggregation, this technique can then be used to test the 
effectiveness of aggregate preventing additive and elucidate the mechanism through 
which prevention occurs. 
Work here also focuses on the mobility of proteins during refolding, using fluorescence 
anisotropy; a rarely utilised technique in relation to aggregation and attempts to 
understand what relationship may exist, if any between a proteins mobility and its 
propensity to aggregate. 
The following chapters detail the body of work which uses these techniques to 
contribute to the literature of protein aggregation and examines methods of reducing its 
occurrence. 
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Chapter 2 : Literature Review 
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2.1 Protein Structure 
There is a large amount of literature that covers the topic of protein structure [1, 2]. 
Proteins are responsible for the vast array of biological functions seen in all organisms. 
Functions range from large scale enzymatic action and breakdown of substrates, to 
delicate and complex environmental regulation. This range of actions is performed by 
molecules which consist of a very similar basic structure, but slight variances in this 
structure confer large differences in their function.   
Proteins are long polypeptide molecules that consist of a chain of multiple amino acids. 
This number of amino acids can vary between tens; in the case of peptides, to tens of 
thousands; the largest being the muscle protein Titin at over 34000 residues [3]. The 
amino acids themselves contain an identical backbone structure consisting of one amino 
and one carboxy terminal, linked by a carbon (Error! Reference source not found.). 
Error! Reference source not found.Attached to this carbon group is the side (R) 
group, which varies between different amino acids, to provide each with an individual 
structure. It is these amino acids, and the sequence in which they are combined, which 
determines the structure, and thus the function of the protein. 
 
Figure 2.1 A typical amino acid structure. R represents the functional group of the amino acid. 
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2.1.1 Primary Structure 
There are 21 amino acids present in eukaryotes. Each of these amino acids consists of a 
backbone structure which is identical to all amino acids, and the variable R group. The 
different R groups confer different properties to the amino acid. These properties 
include; hydrophobicity, hydrophilicity, the ability to pack tightly and disulphide bridge 
forming capability. The full list of amino acids are pictured (Table 2.1) are arranged into 
groups according to some of these properties. The primary structure of a protein 
corresponds to the order in which these amino acids are present. 
The amino acid chain is created by linkage of the individual amino acids through 
formation of a peptide bond between the amino and carboxy groups on neighbouring 
amino acids (Figure 2.2). This is a planar bond; due to the partial double bond 
properties, which allows for the variable R groups to protrude from the side of the 
amino acid, allowing them opportunity to interact with similar R groups at distant 
locales on the peptide chain. 
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Table 2.1:Amino acid structures grouped by properties. 
Hydrophobic: 
Alanine Glycine Isoleucine Leucine Methionine 
 
   
 
Phenylalanine Proline Tryptophan Valine  
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Hydrophilic 
Asparagine Cysteine Glutamine Serine Threonine 
 
   
 
 
Selenocysteine 
 
 Tyrosine 
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Negatively Charged Positively Charged 
Aspartic Acid Glutamic Acid Lysine Arginine Histidine 
 
   
 
 
Figure 2.2: Amino acid linkage. The peptide bond is highlighted in red. 
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2.1.2 Secondary Structure 
In addition to R group interactions, the protein chain also has possibility for hydrogen 
bonding. The two moieties either side of the peptide bond are capable of forming 
hydrogen bonds in both directions (Figure 2.3). Although these are relatively weak 
interactions, a large number of these non-covalent bonds can confer strength to the 
protein structure. Instances of such large scale hydrogen bonding frameworks are α-
helices and β-sheets, which are prime examples of protein secondary structures .The α-
helix is characterised by a protein chain completing a full 360 
o
 spiral every 3.6 amino 
acid residues (Figure 2.3). This is the most common helical structure and forms a right 
handed turn. Helices can range in size from under 10 residues to over 50. 
This structure commands a large degree of flexibility from the constituent amino acids, 
as the prerequisite backbone torsion angles between the neighbouring carbons are very 
specific, which only certain combinations of residues are capable of filling. Amino acids 
that are flexible such as glycine and alanine are often present in α-helices, where as 
proline would only ever be present at the terminus of the structure. Hydrogen bonding 
occurs between every 4
th
 amino acid, which are oriented so that the side R groups face 
outward, as inward pointing side groups would be unlikely due to steric hindrance. 
Across the length of the α-helix, there will be multiple side chain groups pointing out of 
the same side. This allows for a large scale area, or side, of the protein structure to have 
a property such as hydrophobicity if all corresponding residues carry the same 
characteristic. This then allows for the whole region of the helix itself to have this 
property, enabling it to fulfil structural duties on a larger scale such as embedding in a 
membrane.  
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A second most common example of the secondary structure of proteins is the β-sheet 
Figure 2.4, Figure 2.5).  This consists of a helix-like strand of amino acids, with two 
residues for every turn. This allows for the residues to hydrogen bond to a second 
section of the protein chain that is running parallel to it. This second chain is also 
capable of hydrogen bonding to a third, and this behaviour can continue, with 2 to over 
10 strands linked together in order to form a sheet like structure. There are two varieties 
of β-sheet, parallel and antiparallel; these names describe the orientations of the 
neighbouring strands; parallel sheets have identical atoms opposite each other (Figure 
2.4), whilst in the antiparallel strands, the atoms opposite each other are non identical 
(Figure 2.5). Due to the orientations of the bonds, the parallel β-sheets are also less 
stable than their antiparallel counterparts.  Similarly to the α-helices, there are some 
amino acids which are more commonly found in β-sheets than others. Prime examples 
of these amino acids in β-sheets include isoleucine, tyrosine and valine. 
Figure 2.3: The structure of the α-helix. Adapted from [1]. 
“R” Side group
“R” Side group
3.6Å per 
360O turn.
Hydrogen bonding 
between N and O
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Figure 2.4: Parallel β-sheet structure. Atoms are colour coded: Carbon – black, Nitrogen – blue, Oxygen – pink, 
Hydrogen - white. Adapted from [1]. 
 
Figure 2.5:Antiparallel β-sheet structure. Carbon – black, Nitrogen – blue, Oxygen – pink, Hydrogen- white. Adapted 
from [1] 
Although considered a sheet like structure, large β-sheets incorporate a right handed 
turn which is caused by the presence of the R group side groups. In order for these 
functional groups to achieve their most energetically favourable positions, the backbone 
must contort, resulting in the turn. This property allows them to form large β-barrel 
structures. An example of such a secondary structure feature can be seen in green 
Hydrogen bonding 
between N and O
“R” side groups
Hydrogen bonding 
between N and O
“R” Side groups
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fluorescent protein (Figure 2.6). Here the beta sheet structure forms a protective barrel 
which allows the chromophore within the cylinder to fluoresce. Similarly to α-helices, 
the protruding side groups on β-barrels can confer properties such as hydrophobicity to 
the structure. Such a property would enable the β-barrel to be anchored into a membrane 
in order to form a transmembrane pore, which is a common utilisation of the β-barrel. 
 
Figure 2.6: β-barrel structure of green fluorescent protein, protein data bank code: 1GFL [1]. 
These make up roughly 50 % of the total structure elements. Other elements include 310-
helix, π-helix and the β-turn. These structural elements perform different roles within 
the protein structure, but are in essence very similar chemically. It is the order in which 
these chemical groups are arranged which determine these varying structures, and it is 
these structures present within a protein that contributes to its function. 
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2.1.3 Tertiary and Quaternary Structure 
The tertiary structure represents the arrangements of the secondary structural elements 
in three dimensional space. These secondary structural elements may be brought 
together by hydrophobic nature of their respective surface residues, or long ranging 
disulphide bonds through distant cysteine residues. The interactions between the thiol 
moieties (Table 2.1) on the amino acid R groups can be long ranging. They are more 
prevalent in larger proteins, and are responsible for bringing structures from distant 
parts of a protein molecule closer together. An example of this is lysozyme (Figure 2.7) 
where both α-helices and β-sheets contain hydrophobic residues which congregate at the 
proteins core. In addition to this, there exists three disulphide bonds which bind the α-
helices to the outlying polypeptide chain. 
 
Figure 2.7: Structure of lysozyme from protein data bank code 2LYZ [1]. 
 
Quaternary structure is similar to tertiary in how the structural elements interact, but 
differs by the fact that quaternary structure is an interaction between separate 
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polypeptide chains to create the overall protein structure. This may be the assembly of a 
number of identical sub units to create a tetramer, or the association of separate protein 
subunits to create the overall globular protein. An example of such quaternary structure 
is bacteriorhodopsin, where 3 α-helical subunits associate to form the trans-membrane 
protein (Figure 2.8). The arrangement of the structure of the protein, which is primarily 
determined by the proteins amino acid sequence, enables it to perform its function as a 
protein pump which fuels ATP synthesis in bacteria. 
 
Figure 2.8: Structure of bacteriorhodopsin containing 3 subunits. Protein data bank code 1FBB [1] . 
.  
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2.2 Protein Folding 
The general processes and mechanisms behind protein folding are well understood [2, 
3]. As the previous section has shown, a protein’s structure depends on the primary 
sequence of amino acids present within the chains. As such the primary sequence is also 
responsible for the folding of the protein to achieve the final protein structure. 
Understanding of the topic of protein folding has wide ranging implications from 
understanding the nature of diseases to further improving therapeutic protein 
production. Many in vitro experiments have been conducted in order to better 
understand the folding mechanisms of individual protein types and to improve 
understanding of their general formation [4-6].  
2.2.1 Protein Folding in vivo 
For a protein to fold properly as it emerges from the ribosome it must form a native, 
functional state. This native state essentially requires all the backbone torsion angles of 
the residues within the protein chain to achieve their individual set values. If this were 
to occur by the protein randomly adopting different states until it reached the native 
state, the time for a protein to fold would be impossibly large, even given the most 
generous estimations for adopting one state. This is known as Levinthal’s paradox [7].  
The specificity for protein structure is held within the primary structure; the amino acid 
sequence. This folding is driven through conformational entropy, the presence of 
hydrophobic and charged residues force the collapse of the protein structure in order to 
exclude water and achieve more energetically favourable states. The native state of the 
protein has a lower free energy than the unfolded state, and this is achieved through 
burying the hydrophobic residues within the protein core, and presenting hydrophilic R 
groups to the surface [2]. 
37 
 
The hydrophobic driving force can be described in terms of entropy. The unfolded 
protein presents a large amount of hydrophobic residues to the surrounding water 
molecules. This does not allow opportunities for hydrogen bonding, and so the water 
molecules have a low degree of freedom; they are ordered and have low entropy. The 
folded protein presents only hydrophilic residues, these are polar and allow for 
hydrogen bonding to take place with the surrounding water molecules [8]. This enables 
the water to have a higher degree of freedom and thus higher entropy [9]. 
There also exists some opposing entropic forces to this folding, as the folded protein 
itself is more ordered than the unfolded protein. This leads to a negative change in 
entropy during folding. However, this entropy change is minute compared with the vast 
positive entropy change seen in from the exclusion of water from the proteins core, 
hence folding occurs [9]. 
In vivo, protein folding is assisted by molecules called chaperones [10]. Chaperones 
such as the hsp70 proteins are small molecules which bind to the unfolded hydrophobic 
areas of protein as it emerges from the ribosome [11].  This binding prevents regions of 
the protein from associating with themselves to form a non-native state before the full 
sequence of the peptide chain is produced. Additionally, the chaperone binds to, and 
releases, hydrophobic peptide regions which cause local unfolding of the protein, 
allowing it to overcome kinetic obstacles to achieve the native state. There also exist 
larger chaperones, known as hsp60-like proteins [12], which are larger and are used to 
facilitate the folding of mis-folded proteins by enveloping their entire structure. This 
prevents interactions with other proteins which may lead to aggregation, whilst also 
binding and releasing the protein until the natively folded structure is formed [13]. 
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The structural formation described here occurs on the millisecond time scale [14], and 
as a result the protein is in a near-native state [15]. Following this, the protein may 
undergo more time consuming modifications in order to reach its native state. An 
example of this involves the packing of side chains [16]; the near-native protein exists 
in a molten globule state, where secondary structure is formed, but full tertiary structure 
is not. The remaining exposed side chains pack into energetically favourable positions 
in order to complete the tertiary structure [17]. This process occurs over a larger 
timescale than the first folding stages and can take some seconds to complete folding. A 
further example of large time scale structural modifications is proline isomerisation. A 
small percentage of proline residues exist in a cis orientation, whereas the majority of 
the amino acids in the peptide chain exist in the trans form. In order to amend this for 
the protein to form its native state, geometric isomerisation is performed by an peptidyl-
prolyl-isomerase enzyme [18]. This is a process that occurs in the late stage of protein 
folding, much like the formation of disulphide bridges that finalises the native structure 
of the protein. These processes finalise the structure of the protein enabling its 
functionality. 
2.2.2 The Molten Globule State 
The general identifying features of the molten globule structure of a protein have been 
stated as follows: a moderately compact structure (much more so than the unfolded 
state, but less compact that the native), and mobile protein side chains in partially 
structured conformations [19]. The molten globule state of proteins proves difficult to 
characterise in its entirety, due to its changing structure and short existence period. 
There has been much research into the molten globule due to its important role in 
protein folding and the implications this holds for many research areas into protein 
structure and function [20]. The molten globule state can be identified as a statistically 
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sufficient number of the protein population which are in a stable state, as opposed to 
there being a large number of very unstable intermediates [21]. 
Elsewhere, from the researcher who coined the term, it is described as a compactness 
and presence of secondary structure, with no rigid tertiary structure and a little expanded 
in comparison to the native state [22]. The overall concept of the molten globule state is 
one whose secondary structure content varies little from the native state [23], but whose 
tertiary structure is fluid as the side chain positions are mobile [24]. 
In order to better illustrate the careful energy barriers which the molten globule state, 
and indeed the native state occupies, protein energy basin diagrams have been adopted. 
The energy basin illustrates protein folding in the form of a landscape, where instead of 
a small number of intermediates present between unfolded and native, there are a 
multitude of conformations that can be adopted in the path to the native state [25]. The 
energy basin diagrams show the double stage folding process and illustrate the energy 
required to overcome undesirable non-native states of the protein [26].   
Figure 2.9: The protein folding funnel. Based on [9]. 
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The initial hydrophobic collapse of the unfolded protein is represented by the smooth 
slope with a downward gradient. This is the first stage within Figure 2.9, where the 
intermediate states are more stable than the unfolded state. This has been proved in both 
acid unfolding experiments [27], and computer simulations [28]. The second stage 
represented is the molten globule state, with multiple metastable states that have energy 
barriers that must be overcome to reach the native, most energetically favourable state. 
In vivo this stage is assisted by chaperones. 
Without sufficient energy, the protein will remain trapped in one of these local minima 
in a misfolded, or non-native state. Within the cell, presence of these misfolded proteins 
can carry out alternate physiological actions than their intended function, such as 
cytochrome C; where a misfolded conformation of the protein is capable of causing 
apoptosis in the cell [29]. More serious implications of the presence of non-native 
proteins within the cell include the formation of amyloid fibrils, which are responsible 
for diseases such as Alzheimer’s, Parkinson’s and Creutzfeldt–Jakob disease (CJD). 
This form of protein aggregate has been shown to form from molten globule 
intermediates [30], even to the extent where there is a large change in the secondary 
structure content of a protein from the native state [31] and these proteins have been 
shown capable of inducing a change to the non-native state from neighbouring proteins, 
increasing the proliferation of the non-native population [32]. This illustrates the 
importance of work into the molten globule state and protein folding pathways, as 
research shows that the native state has competition from protein aggregates as the most 
thermodynamically favourable minima on the folding landscape [33, 34]. The topic of 
protein aggregation will be discussed in detail further in this chapter. 
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2.2.3 In vitro protein folding 
The vast majority of in vitro folding research focuses on recombinant proteins. 
Procedures for recombinant production of proteins focus on two areas: obtaining the 
highest yield of native protein structure and ensuring this sample is solely the native 
protein. In most cases the end product is the goal, rather than understanding the 
mechanisms that help achieve it. Recombinant protein produced from bacterial cells is 
in such a high concentration that it forms large aggregated masses, known as inclusion 
bodies [35].  These bodies are unfolded using high levels of denaturant and refolded by 
dilution or dialysis in order to achieve the native state [36]. Additives may be added to 
the refolding conditions in order to assist the protein in achieving the native state, such 
as metal ions around which the protein may fold. These conditions will differ depending 
on the protein. The refolded sample will not consist solely of the native state protein, 
and some aggregates will remain, therefore separation procedures such as ion exchange 
and size exclusion chromatography are required in order to achieve a sample of protein 
monomer [37]. Native structure determination can be performed by techniques such as 
circular dichroism, NMR and protein crystallography in order to determine that the 
native state of the protein has been formed [38, 39]. 
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2.2.4 Protein Folding Research 
Early protein folding research concentrated on some simple model systems. Proteins 
such as lysozyme and α-lactalbumin were often used in such experiments as they were 
able to be purified in large quantities for experimentation, and are simple α-helical 
proteins, which allowed the kinetics of their folding and secondary structure formation 
to be investigated with ease [40]. Many of the protein folding properties discussed 
previously in this chapter were elucidated from work on these proteins [41].  
Additionally the small size of the proteins allowed them to be studied without the need 
for multiple kinetics rates for separate domain folding [42]. These model systems have 
been used in more recent work for probing the molten globule state, in the case of 
lysozyme its molten globule state has been shown to have a low affinity for calcium 
metal ions [43] which may affect its propensity to aggregate. A further example of these 
well characterised model systems is β-lactoglobulin, with similar characteristics to 
lysozyme and α-lactalbumin, the timescale of hydrophobic collapse has been elucidated 
for this protein [44]. Here the authors show that it takes only 100ms for the protein to 
collapse to 1.1 times its native size, and similar times are assumed for the timescale of 
folding for other model proteins. Further work on protein folding kinetics has extended 
to the use of computer simulations to investigate what factors contribute to the timescale 
of protein folding, such as the impact of the sequence properties on the speed of protein 
folding [45]. The history and ease of use of these proteins make them ideal for further 
studies on generic properties in the protein folding process. 
In addition to assigning a timescale to the process of protein folding, much work has 
been performed to elucidate the mechanisms through which proteins fold and unfold. 
Examples include using both extreme temperature and pH in order to induce a molten 
globule like state from proteins in order to study the molten globule state [46]. The 
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rapid nature of the native folding process is too quick for the majority of characterising 
techniques, therefore techniques involving sub zero temperatures have been used to 
slow down the process of protein folding to better understand the mechanism by which 
β-lactoglobulin folds [47]. Complimentary to this, unfolding studies have been 
performed to sequentially break the bonds forming the structure of the native protein in 
the assumption that this action is the reverse of the mechanism of protein folding. 
Increasing concentrations of denaturant are added to the protein, and the binding 
energies of the protein backbone are elucidated [48] which covers a larger timescale 
than the folding process. This technique has also been used alongside size exclusion 
chromatography in order to quantify the sizes of protein molecules in multiple 
disordered molten globule states [49]. 
Most recent work in the area of protein folding has centred on the role protein folding 
plays in the formation of protein aggregate formation. It has been shown that the folding 
of lysozyme in a crowded environment results in the formation of lysozyme aggregates 
which lack the enzymatic activity of the native state [50]. Experimental methods have 
also been developed in order to monitor the extent of the aggregation during folding 
using fluorescent probes [51], and also into methods which can be used to reverse the 
aggregation process resulting from folding such as the use of denaturants and high 
pressure to return the protein to the native state [52], which has been shown possible for 
aggregates of a number of different proteins. A large focus of the work centres on 
prevention of formation of aggregates. If mild concentrations of denaturant are present 
within the refolding environment, the extent of aggregation is lower than if there is no 
denaturant present. This is thought to occur by stabilising the aggregation prone molten 
globule state by the denaturant [53]. Although fairly comprehensive, there is little in the 
literature which relates the mobility of the molten globule state to the likelihood of 
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aggregation, especially involving real time studies which are more informative on real 
life processes. 
A large amount of work on preventing aggregation involves studying the effect 
chaperones have on protein folding, as in the cell they are known to facilitate this 
process [54]. Work has been performed to look at the interactions between protein (α-
lactalbumin) and chaperone (GroEL) [55] and how they bind. Also investigating the 
effect of ATP dependence between a chaperone and protein [56], which shows how 
cycles of ATP binding are responsible for the facilitated folding of α-lactalbumin. 
Further to this, additional studies have monitored the states of the protein inside the 
chaperone, in order to understand the conformational changes that the protein undergoes 
whilst in contact with the chaperone [57], the chaperone appears to be responsible for 
binding to aggregation prone regions of the protein, and releasing them when the 
environment is suitable enough for them to fold into the stable native state in order to 
prevent aggregation [58]. Understanding the role chaperones play and their interactions 
with the various states of the protein can elucidate routes through which proteins 
interact to aggregate and therefore offer a route to prevention of aggregation. 
2.2.5 Techniques for Studying Protein Folding 
One of the most elementary techniques used to study the folding of proteins is 
tryptophan fluorescence. Tryptophan amino acid residues fluoresce under ultra violet 
light when they are exposed, such as when the protein is unfolded, but when the protein 
has collapsed and the tryptophan residues are buried and there is a significant difference 
in the fluorescence signal of the residue. These properties of tryptophan fluorescence 
have long been exploited as a method for determining the extent of protein folding [59]. 
Tryptophan fluorescence is also used extensively in the characterisation of protein 
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folding pathways, prime examples include α-lactalbumin and lysozme folding [60]. 
External effects on the extent of protein folding have also been probed using this 
technique, such as the effects of temperature and pH [46], or the effect of additives such 
as urea to the protein environment [53]. On its own, this technique is very qualitative 
and is often run to complement other techniques, such as those mentioned below [46]. 
Circular dichroism is a technique which allows determination of the secondary structure 
of a protein [40]. In terms of studying protein folding, research has attempted to study 
the sequences of secondary structure formation in specific proteins [61]. This technique 
however is not as capable at performing  real time dynamic experiments, and requires 
the stages of folding to be slowed down, such as step-wise unfolding processes [62], or 
alternatively performing the refolding experiments at sub zero temperatures [47]. 
Examples of the techniques used include secondary structure characterisation of β-
lactoglobulin [63] and cytochrome C [64], whilst more recently it has been used in 
conformational studies of recombinant therapeutic proteins [65]. Despite these 
restrictions, circular dichroism is an invaluable tool for understanding the state of 
protein secondary structure, and is often used in tandem with other techniques to verify 
the quality of the protein fold [60]. Additionally, synchrotron radiation circular 
dichroism is an improved technique which allows for further structural features to be 
characterised, and is capable of providing dynamic structural information [66]. 
A third commonly used method for monitoring protein folding is the use of 1-
anilinonaphthalene-8-sulfonic acid (ANS) in folding experiments. This chemical binds 
to available hydrophobic regions on a protein and fluoresces. As the protein collapses, 
the ANS becomes unbound, and the fluorescence is lost. These features have been 
exploited in order to monitor the hydrophobic collapse of protein folding systems [62]. 
This method is ideal for looking at dynamic folding of a protein, and has often been 
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used to elucidate the molten globule state [53]. In addition to its more common use, 
ANS has also been shown to be capable of binding to protein aggregates formed from 
folding experiments, to give an indication of the aggregate quantity being produced 
[51].  Whilst useful in characterising hydrophobic collapse, the absence of ANS 
fluorescence does not indicate the absence of folding, and requires complimentary 
techniques to provide a full picture of folding. 
In addition to these common techniques listed above, less orthodox methods have been 
used to complement these works. In order to better understand the contribution of 
different residues to a proteins fold, proteolysis experiments have been carried out 
where specific residues are cleaved from the protein, and the kinetics of the novel 
protein is then compared to that of the native [67]. Similar experiments have been 
undertaken where mutagenesis is used; selected residues within a protein are mutated 
and their contribution to the fold measured [68]. In addition, NMR has also been shown 
to be a capable tool for monitoring the structure of both the protein and its molten 
globule counterpart [46, 60]. Some techniques which are capable of monitoring protein 
monomer size have also been utilised to observe the hydrophobic collapse of the 
protein. Examples include small angle X-ray scattering [44], SDS page [61] and size 
exclusion chromatography has also been used for monitoring the unfolding states of 
proteins [49] where the timeframe of the collapse can be characterised by the protein 
hydration radius decreasing. Attempts have also been made at predicting protein folding 
kinetics and timescales through the use of computer simulations [45]. Finally, an 
emerging technique for monitoring the process of protein folding is single molecule 
Förster resonance energy transfer (FRET). As it is examining the fluorescence of just a 
single molecule, instead of the average of a whole population of protein folds, FRET 
promises to provide insight into exact timescales for protein folding processes [69], and 
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has been utilised to measure more complex systems such as interactions with 
chaperones [58]. Whilst the characterisation of protein folding offered by these 
techniques is vast, none characterise the extent of mobility in the molten globule state, 
or how this relates to the aggregation proneness of the protein molecule.  
2.2.6 Unfolding Methods 
Protein folding experiments in general require the protein to become unfolded in order 
to be able to emulate the folding process. Some of the most common methods include 
the use of denaturing additives which are added in a concentrated amount to unfold the 
protein and then diluted in order to initiate folding [48]. Acids have been known to be 
used to denature a protein [55]. The high charge present at low pH acts to destabilise 
any intra protein charge-charge interactions, as such the unfolded state becomes more 
stable at low pH than the native [70]. However this conformational behaviour is not 
present in all proteins [71], especially in those whose native environment is acidic. 
Denaturants most commonly used are urea [44], and guanidine hydrochloride [43]. High 
concentrations of these molecules perturb the protein structure through interaction with 
hydrogen bonding groups which results in a decrease of the proteins entropy and 
enthalpy [72]. Urea at high concentrations is capable of maintaining the unfolded 
protein through direct interaction with the polar residues within the protein and 
additionally through reducing the hydrophobic effect the surrounding water exerts on 
the protein residues [73]. Whilst these are efficient at unfolding the protein, by diluting 
the solution there will always remain a residual amount of denaturant in solution.  
In contrast to this, temperature has also been used to denature proteins either to study 
the strength of bonds [74], or in order to then initiate folding [46]. By providing the 
energy to overcome hydrogen bonding within the protein, a temperature jump to above 
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the protein’s melting temperature will result in complete unfolding of the protein where 
it may adopt multiple intermediate conformations in the pathway to the unfolded state 
[75]. However this method may also initiate aggregation, where inter-protein 
interactions will contribute to any energetic characteristics obtained from these studies. 
2.3 Protein Aggregation 
Protein aggregation occurs when a protein is subjected to unfavourable conditions 
(generally non-native), which cause structural deformation in the protein structure. This 
structural change can lead to the molecule being prone to self association, where it may 
interact with a similarly perturbed protein molecule to form an aggregate, generally 
resulting in loss of function of the two protein monomers [76]. The protein aggregate 
may then act as a nucleation site for aggregation, interacting with additional structurally 
perturbed monomers to form a larger aggregate. 
Protein aggregates are found in a number of shapes; fibrous protein aggregates are 
commonly seen in neurogenerative diseases such as Creutzfeld-Jakob and Alzheimer’s 
diseases [77]. Amorphous aggregates are a second class of aggregate which are most 
notably present in inclusion bodies in cells where a large concentration of non-natively 
folded protein occupies a small volume [78] and particulate aggregates which are 
spherical and have been formed in vitro through thermal aggregation in conditions near 
the isoelectric point of the protein [79]. 
As can be seen in the variety of structures aggregates may form, the study of protein 
aggregation carries importance in many areas [80]. Protein aggregates have been shown 
to be precursors to a number of neurodegenerative and prion diseases [81]; where 
understanding the formation of these aggregates may elucidate a route to treatment. 
Prevention of protein aggregate formation also plays a pivotal role in the production of 
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biopharmaceuticals, where proteins are produced in such quantities that they form 
aggregates in the inclusion bodies. These aggregates are non functional and therefore 
represent a loss in yield during production [82]. In addition, any presence of protein 
aggregates in therapeutics have been shown to cause immunogenicity, where the 
presence of the aggregate can cause the body to raise antibodies to the natively folded 
protein, nullifying any therapeutic effect [83]. 
2.3.1 Thermal Unfolding 
Temperature dependant unfolding of proteins occurs when a protein in its native state is 
subjected to a sufficient temperature increase to overcome the thermodynamic stability 
of the protein. This process is endothermic as energy input is necessary for overcoming 
barriers to unfolding such as disrupting salt bridges and breaking hydrogen bonds that 
maintain the proteins tertiary structure. As the temperature of the protein increases, it is 
seen that the strength of hydrogen bonds and hydrophobic interactions gradually 
decreases [21]. The strength of these bonds continues to weaken and after increased 
heating to above the melting temperature the protein is denatured. This causes a loss of 
function and tertiary structure, resulting from the protein becoming partially unfolded.  
The thermal unfolding of proteins has been seen to begin with the loss of tertiary 
structure dependent contacts [84], forming an intermediate, partially unfolded state, 
although not mentioned in the quoted paper, it bears resemblance to the molten globule 
state. The order of this unfolding may depend on unfolding temperature and the 
temperature at which simultaneous breakage of all structural bonds occurs; tΩ. [74]. In 
this paper, Cieplak et al. suggest from a molecular dynamic model, that below tΩ, 
protein unfolding occurs similar to the reverse order of folding, which appears to agree 
with the findings from Li et al. [84] above, where loss of tertiary structure is the first 
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step in thermal perturbation of the protein. Additionally, this seems consistent with the 
findings that the molten globule state is a prominent phase in protein folding [22]. 
Above tΩ however, the bond breakages within a protein are seen to occur at once, 
showing no preferential order of unfolding [74]. This more comprehensive denaturation 
would include removal of the large number of weak intermolecular interactions that are 
responsible for the secondary structure and hydrophobic packing. These bonds 
contribute to the stability of the protein when in its molten globule state, so therefore 
this state will not be present when unfolding occurs above tΩ. It would appear this 
characteristic is important, especially when considering refolding of the protein, as it is 
seen that protein denaturation can be reversible, but it depends on the types of the bonds 
which are broken [21], where peptide chain hydrolysis is an irreversible process. 
The thermal unfolding of a protein, including the strength of bonding during its 
unfolding transitions, can be characterised by measuring the change in specific heat 
capacity; ∆Cp [85]. The heat capacity indicates the amount of energy required to 
increase the temperature of on mole of the protein by one degree. Specifically in protein 
unfolding measurements; this indicates the amount of heat energy required to break the 
bonds within the protein. The larger this value, the more highly structured and stable the 
protein is likely to be. This value is seen to be a highly positive change during each 
stage of protein unfolding [21]. This is relative to the high number of bonds broken, 
including many of the weak secondary structure interactions that are an inherent feature 
of the structure of the proteins intermediate states. As the protein becomes unfolded, it 
exposes hydrophobic residues, which are responsible for the interactions leading protein 
aggregation [86] in addition to the higher flexibility in the backbone of the partly 
unfolded state.  
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A further method for characterising protein unfolding is through the calculation of the 
melting temperature; the temperature at which half of the protein within the sample has 
been unfolded.  A large melting temperature corresponds to a strong and highly stable 
conformation which is unlikely to unfold. Furthermore, multiple melting points can be 
extracted from this method, indicating the strengths of individual domains of the 
protein.  Papain was shown to have 2 transitions in melting temperature; this was 
interpreted to represent the two separate domains of papain melting to give the molten 
globule conformation [62]. Additionally, this can reveal the presence of any stable 
intermediates that are formed within the unfolding process through the presence of the 
multiple melting temperatures [86]. Both the heat capacity and the melting temperature 
are common properties of proteins measured commonly by differential scanning 
calorimetry [87]. However as previously noted, during protein heating aggregation may 
also occur, and separating the unfolding energies from the contribution from 
aggregation is not considered. 
2.3.2 Thermal Aggregation 
Protein aggregation is proposed to be a universal characteristic of polypeptide chains 
when the native interactions normally present in the protein are destabilised, leading to 
an increase in hydrophobic interactions occurring between protein molecules [88, 89]. It 
has been shown with bovine serum albumin that only a small change in tertiary 
structure is necessary before aggregation occurs [90]. The hydrophobic exposure from 
the loss in tertiary structure is responsible for the formation of aggregate nuclei, 
initiating aggregation [91]. These nuclei are capable of propagating aggregation by the 
conversion of additional perturbed protein monomers [92].  
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The aggregation stage consists of an exothermic irreversible process; which is 
dependent upon the initial rate of formation of aggregate nuclei to determine the 
kinetics of aggregation thereafter [93]. The aggregation process may not occur 
immediately after structural perturbation begins however [94].  
2.3.3 Aggregate Nucleation 
Aggregate nucleation takes place where the conformational change in a monomer 
results in the binding of a second or multiple monomers whose conformation also 
differs from that of the native state. It is the initiating step in the aggregation process, 
most relevantly shown in the thermal aggregation of α-chymotrypsin A [95] where it 
has been postulated that the presence of the non-native aggregate prone monomer may 
encourage conformational change within other native protein molecules as it provides a 
lower energy barrier for the conformational change to occur. This nuclei then acts as a 
seeding template from which further monomer addition is facilitated [96]. When a large 
number of nuclei are present throughout the sample, the aggregation process flourishes. 
An alternative method of action proposed is that there is already a low energy barrier 
between native monomer and the varying intermediate conformations. The rate of 
aggregate nuclei formation would be proportional to the concentration of monomer, and 
it is solely the collisions between intermediate molecules that drives aggregate 
formation [97]. In order for a nucleus to seed aggregation, it must remain stable for 
sufficient time for growth to occur from it. As growth is considered to be a slower 
process than the nucleation phase, the nuclei must remain for a substantial period of 
time. However in situations where very rapid growth occurs even the formation of 
reversible nuclei may seed the aggregation process [98]. 
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It has been suggested that the protein monomer in a partially folded conformation may 
be the most prone to form an aggregate nuclei; even more so than the completely 
unfolded protein [99]. The explanation is that the hydrophobic areas in a partially folded 
protein would be exposed, but still grouped, offering a more concentrated area for 
aggregate interaction. However in the unfolded state, the hydrophobic residues would 
be randomly oriented around the backbone [100]. Within this paper, denaturants are 
used to maintain the unfolded state of the protein. It must be noted that the increasing 
denaturant concentration will play some contributing role to the effects seen here, as the 
urea molecules will be present around hydrophobic areas of the unfolded protein. Here 
they compete with the monomers for interactions with the protein, probably leading to a 
decreased rate of aggregation over “pure” unfolded protein. 
Opportunities for these aggregate prone monomer species to appear arise when 
considering the protein folding pathway. As the protein occupies multiple states within 
the folding energy basin, one or more of these states may exist in equilibrium with a 
nucleation prone intermediate state. These nucleation prone states are often seen to 
contain a higher level of β-sheet than that which is found in the monomer [95]. In 
addition to this, there are also multiple routes which the folding may take to occupy one 
of these conformations [101]. These routes can be considered in terms of the protein 
energy basin, where changing the conditions within a system will also have an effect on 
the profile of the energy basin. In extreme cases this may make non native 
conformations of the protein the most energetically favourable, promoting aggregation. 
The nucleating monomer can be present in many forms; within the same type of 
monomer across multiple conformations [98, 102] and during folding where aggregates 
begin to form even before stable unfolding intermediates are present [103]. Furthermore 
it has been shown that aggregation can be prevented through the use of high pressure 
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during the unfolding stage, it is postulated by the author that this is because the high 
pressure physically prevents the unfolding process occurring at comparable 
temperatures [93]. 
The number of partially unfolded monomers required to create an aggregate nucleus can 
vary between systems. The formation of dimers has been shown to be sufficient to 
nucleate aggregation [104-106], but also oligomers [107] and larger nucleation sites 
formed from micelles in the case of amyloid β protein [108]. Furthermore the smallest 
stable aggregate nucleus of a short polypeptide chain has been shown to be in the 
multimer range [109] and in these circumstances, formation of any reversible aggregates 
is considered a pre-nucleation step. Here the trend seems to be that larger molecules 
require fewer numbers of monomer create a stable aggregate as they offer more protein-
protein interaction opportunities than smaller molecules, which therefore require a 
larger population. 
In the aggregation model which consists of both nucleation and growth phases [110], 
the nucleation stage is considered to be the rate limiting step within the system [102]. 
However, in the system of particulate aggregation investigated here, all nucleation sites 
are thought to form simultaneously [79], where only a process in the monomer addition 
stage can be the rate limiting factor in growth. 
Once nucleation has occurred, there are multiple ways in which aggregation might 
progress, depending on the concentration within system. There may be minimal growth 
whilst the aggregates remain in solution, there might be rapid growth to larger insoluble 
aggregate, or a formation of a gel phase may occur if the concentration is sufficiently 
high [98] [111]. 
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2.3.4 Aggregate Growth and Structure 
Protein aggregation can take a number of forms and is dependent upon the 
environmental conditions the proteins are subjected to during the aggregation process. 
The most commonly investigated of these is the amyloid fibril, but in addition to this 
there are also particulate and spherulite aggregates, which have been shown to be 
formed from proteins which also aggregate into amyloid fibrils [79, 112, 113]. These 
aggregation characteristics have been proven for multiple proteins whose structures and 
functions are unrelated, which leads to the assumption that these characteristics are 
properties of all proteins. 
Fibril formation is formed from highly charged protein molecules. These charged 
molecules provide long ranging repulsion, which only allows for further proteins to bind 
in a small number of arrangements. This type of aggregation particularly favours the 
formation of β-sheets and leads to a one dimensional formation of aggregate growth 
[113]. The formation of ordered aggregates of BSA was discovered when forming 
amyloid fibrils away from the isoelectric point [90].  The mechanism of aggregation in 
BSA was additionally shown to include the transformation of alpha helices to β-sheets 
during partial unfolding of the tertiary structure.  
Conversely to fibrils forming in conditions away from their isoelectric point, spherulites 
have been seen to form in a pH region closer to the isoelectric point of the protein. 
These protein structures are not well characterised; but they contain short runs of β-
sheet, forming fibrils which emanate from a central nucleus to give a shaped akin to a 
“maltese cross” as described in the paper [112]. Insulin is shown to form spherulites 
readily [114] whereas β-lactoglobulin only forms them infrequently, generally forming 
at the same time as amyloid fibrils, which possibly shows its dependence on the 
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isoelectric point of the environment for spherulite formation. [113, 115] Spherulites can 
consist of a core of collapsed fibrils in the nucleus. This is one possible explanation for 
how they are seen to occur alongside amyloid fibrils. However, for them to be seen to 
exist alongside fibrils, they must be present in an environment away from the protein’s 
isoelectric point, so it is possible that spherulite formation may be possible over a range 
of conditions. 
Near the isoelectric point, there is a significant barrier to “ordered” aggregation, and 
unlike in fibril formation, there is no long range charge repulsion present. This 
decreases the likelihood of structural rearrangements, and because the aggregation 
occurs in a random and non-specific way, the particulates formed are spherical. [113] 
Proteins that have been proven to form particulate aggregates had all previously been 
shown to form amyloid fibrils under different aggregation conditions. This difference in 
aggregation is completely independent of amino acid sequence, and is determined by 
the general state of the protein in its environment. [79] 
Particulate aggregation occurs around the isoelectric point, where there is a low overall 
amount of electrostatic interactions, therefore there are many arrangements in which 
aggregates can form, which leads to aggregation growth occurring randomly, causing 
the aggregates to be approximately spherical in shape. Particulates can have a size of 
around 250nm and contain some β-sheet content [113]. These particulates have a strong 
tendency to induce aggregation. After particulate aggregation, remaining monomeric 
protein within the solution becomes deposited between the particulates. This leads to the 
appearance of the particulates being connected [79]. 
Particulates, were found to have similar levels of secondary structure after heating when 
compared to the native state in various samples: BSA, Myoglobin, transthyretin; where 
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there was an increase in secondary structure content [79]. Here, aggregation of these 
samples proved that the proteins were not aggregating through disulphide bond 
formation as both myoglobin and transthyretin do not contain the cysteine residues 
required and the aggregation was more likely a result of partial unfolding of the proteins 
The rate of heating is shown to affect particulate aggregation size [79]. The higher the 
heating rate, the smaller the aggregation of the particle, these results led the authors to 
the conclusion that particulate nucleation is determined by the heating temperature, 
where a higher temperature results in more nucleation sites forming, the subsequent 
growth results in a smaller diameter of particle where remaining protein concentration is 
uniformly distributed around each of the particulate nuclei. [116] 
β-lactoglobulin subjected to an environment away from the protein’s isoelectric point 
was shown to form clear and fibrillar gels. Conversely, when the β-lactoglobulin protein 
was present in an environment near the protein’s isoelectric point, the gels formed after 
heating were shown to be opaque and consist of particulates [116, 117] Partial 
denaturation of the β-lactoglobulin occurs at its isoelectric point, this unfolding of the 
protein allows an area in which interactions between molecules can occur, and 
aggregation can be facilitated. This has been shown to be similar for other proteins 
which will at the least partially unfold.  
These aggregation interactions in protein particulates have been shown to interact 
through (sometimes non-native) β-sheet structures [118]. Current understanding 
indicates that this is the same interactions occurring in amyloid fibril formation, 
therefore work on the early stages (i.e. nucleation) of particulate formation may also be 
applicable to that of amyloid formation. In addition, the kinetics and thermodynamics of 
the particulate system are not well characterised in the literature, understanding these 
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factors would not only improve our understanding of the system, but provide numerical 
benchmarks from which aggregate preventing additives may be tested. 
2.3.5 Techniques for Measuring Protein Aggregation 
The following section introduces the main techniques used in the literature to study 
protein aggregates. Though not exhaustive, it covers the techniques used to extract the 
main properties of an aggregate system, namely; shape, structure, size and concentration 
of the aggregates. Examples of their use in the field are included, and the advantages 
and limitations of each are discussed. 
I. Size Exclusion Chromatography (SEC) 
SEC separates protein molecules and aggregates according to their hydrodynamic 
volume [119]. The column used to perform the separation is populated with porous 
silica particles. The protein aggregate sample is passed into the column and the larger 
aggregate particles are excluded from passing through the pores; passing around the 
edges of the beads instead. This results in larger aggregates being eluted from the 
column quicker than smaller aggregates, or monomers which pass through the pores in 
the beads as they travel through the column. The concentration  of the eluted protein can 
be analysed by a spectrophotometer and the size of the particles can be compared to 
elution times for standard particles of known size [120]. Gabrielson et al. showed that 
this technique could be successfully used to quantify the level of aggregation in 
antibody samples [121], whilst Grillo et al. showed how the SEC can be used to 
complement other techniques for biopharmaceutical proteins [122]. SEC however 
requires an extensive knowledge and experience with the technique in order to ensure 
the column has a suitable composition in order to separate the aggregate system, and 
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will generally involve diluting the aggregate sample which in turn may have some effect 
on the aggregation present within.  
II. Static Light Scattering (SLS) 
SLS measures the scattering intensity of light coming from the protein particles, which 
are illuminated by a single wavelength beam of light, and the scattered light is generally 
measured at multiple angles. The time averaged scattering of this data is deconvoluted 
to give information on the size, shape and concentration of the sample. This requires the 
sample to be of high enough concentration to produce sufficient scattering, whilst low 
enough to avoid multiple scattering. This technique can be utilised as the sample passes 
through a column or as a more static sample measurement from a cuvette, although the 
latter involves regular and thorough cleaning of the cell. In addition, for full analysis, 
multiple concentrations of the protein are required, which may cause error if the system 
is concentration dependent. This technique has been shown to be valuable in the 
detection of low levels of aggregate present in samples of immunoglobulin G [123] 
where SLS was used in conjunction with SEC. 
III. Dynamic Light Scattering (DLS) 
DLS is used in a similar manner to that of SLS, but the technique measures the 
fluctuations in the light intensity over time instead of a time averaged intensity across 
multiple angles (as is the case with SLS). These fluctuations are due to the random 
motion of the protein particles through the sample. This information can be 
deconvoluted to give information for a wide range of aggregate sizes and distributions 
[124]. One of the advantages of DLS is that there are no special sample requirements 
involved, and therefore it can be used on the direct sample which is especially useful in 
investigating the kinetics of aggregation. A prime example of the use of DLS is in a 
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study of β-lactoglobulin aggregates to form fibrils [125], where the technique is used 
alongside other scattering experiments to characterise the formation of the fibrils. As 
DLS requires a period of time over which to collect the data and ascertain the sample 
size, it is not suited to dynamic processes such as protein aggregation. Furthermore, 
complex data analysis and a highly refined setup are required in order to resolve 
separate but closely related size populations. 
IV. Analytical Ultracentrifugation 
This technique uses centrifugal force to separate aggregates based on size, and 
concentration through sedimentation equilibrium. This is then quantified using 
absorption or fluorescence spectroscopy. It requires a low amount of sample 
preparation, and therefore can be used to measure the protein aggregate sample directly 
[124]. This technique requires a detailed knowledge in order to separate the aggregates 
sufficiently, much like SEC. Additionally there requires some detailed analysis and 
complex separation issues that can arise from the aggregate solution [126]. 
V. Field Flow Fractionation (FFF) 
FFF uses an external field (generally flow, electrical or magnetic) to separate protein 
aggregates under flow. Coupled with this is the simultaneous measurement of the mass, 
size and charge of the particles within the system, separating the particles due to the 
movement of solution components in different flow channels. FFF has a wide range of 
particle detection from between 1 nm to 100 μm [127] and can be utilised to give an 
excellent separation between particles. There are limited examples of its use in protein 
aggregation where it is only limited to the study of soluble aggregates, but it has been 
suggested that with increasing knowledge of how to extract data from this technique it 
is becoming more useful for analysis of aggregates [128]. 
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VI. Gel Electrophoresis 
Gel electrophoresis uses sodium dodecyl sulphate (SDS) as a denaturant to linearise the 
protein molecules. These molecules have an overall negative charge, as therefore 
migrate through a gel when a current is passed across it. The separation of the protein 
molecules is performed by molecular weight, with smaller proteins migrating further 
down the gel than the larger aggregates. The molecules are then stained by a visualising 
agent in order to quantify the amount of protein present, and their migration distance 
compared to that of a known standard. This is an often used and simple tool for both the 
measurement of size and quantity of protein aggregates, especially when separating 
large ranges of aggregate [129]. However the use of SDS results in only aggregates 
which are covalently linked to still be present within the gel, this may not elucidate the 
full extent of protein aggregation within the sample. This problem may be solved by the 
use of native-PAGE, but there is little evidence for it in the literature at present. 
VII. Microscopy 
Light microscopy may only be used on very large aggregates, where visual inspection 
of particle number and size can be ascertained from the sample by comparison with 
standard samples of known size. It is also possible to have computerised methods of 
particle counting utilising a flow setup for the aggregates [130]. In the sub visible range, 
both transmission and scanning electron microscopy have been used to evaluate 
aggregate size and shape to a very accurate degree. This requires a large amount of 
sample preparation in a vacuum and coating the samples with gold in order to get 
sufficient contrast to see the scanning image [120]. In addition to the lengthy setup 
requirements, microscopy generally deals with a small area of the sample, unlike most 
techniques which are an average representation of the sample as a whole. Despite this, 
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microscopy is often used for sizing of protein aggregates with many examples in the 
literature; Nielson et al. formed insulin fibrils and characterised the length and 
diameters using electron microscopy [131] and elsewhere the effect of bovine serum 
albumin on membrane fouling has been characterised using microscopy to examine the 
structural changes incurred [132]. 
VIII. Spectroscopy 
Fluorescence spectroscopy utilises fluorescent dyes which are natively fluorescent, and 
when bound to a protein aggregate, have a shift in the fluorescent light which they 
produce [133]. Dyes such as 1-anilinonaphthalene-8-sulfonic acid  bind to hydrophobic 
regions on the protein, and have been shown to bind preferentially to protein aggregates 
[134], where they interact through the available hydrophobic regions which are exposed 
on the aggregate. This fluorescence change can be monitored through the use of 
spectroscopy or fluorescence microscopy. A fitting example of spectroscopic dyes being 
used in protein aggregation is in the use of Nile red to monitor the thermal aggregation 
of β-galactosidase [135]. This technique also enables very low levels of quantification, 
however as it binds solely to hydrophobic patches within the protein, it is difficult to 
study aggregates formed through refolding studies as the probe will bind strongly to the 
unfolded protein. 
Additionally, intrinsic tryptophan fluorescence can be used as a measure of proteins 
tertiary structure before unfolding that leads to aggregation begins. This is covered in 
the protein folding section of this work. 
Circular dichroism (CD) and Fourier transform infrared spectroscopy (FTIR) both make 
use of the chiral nature of the protein molecules to analyse the secondary structure of 
the aggregates. The differences in light absorbtion can be translated into a secondary 
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structure content for the protein. These techniques are powerfully accurate, where 
circular dichroism has been used in secondary structure quantification between differing 
self association states of human insulin [136] and FTIR has been utilised to analyse the 
secondary structure content in the aggregates of the same molecule [131]. Whilst these 
techniques are very useful in quantifying secondary structure, they are an average of the 
entire sample, so aggregates present in monomer solutions may need separating before 
successful analysis can be undertaken. 
IX. Ultra Violet Light Scattering Spectroscopy (UVLSS) 
UVLSS is a light scattering technique which utilises a range of wavelengths of ultra 
violet light in a spectrophotometer to calculate the scattering produced from the sample. 
The theory of the technique will be discussed in more detail in the following chapter. 
UVLSS allows the diameters of particles above 50 nm (depending on refractive index of 
the protein) to be measured. A proof of concept experiment has been run where this 
technique accurately sized polystyrene spheres of set diameters [137, 138]. This allows 
for in-situ time resolved dynamic measurements of protein aggregation and from this 
the calculation of monomer depletion and kinetics [139] and unlike some techniques, is 
non-destructive. This is an underused technique but is ideal for monitoring the 
aggregation of proteins on the larger length scales as it does not detect particles of the 
size scale of monomers, therefore data deconvolution is not necessary [140]. However 
this also means that detection of small aggregates or aggregate nuclei is not possible 
using this technique.  
X. Small Angle Scattering 
Small angle scattering utilises a beam of either neutrons or X-rays which is directed 
towards a sample and scattered onto a detector. This scattering gives information on 
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particle size shape, concentration and interactions [141]. This will be covered in more 
detail in the theory section. This technique offers a wide range of sample environments 
for studying many systems, including proteins [142]. Details from the system can be 
extracted by modelling the system and comparing the modelled profile to the 
experimental. This can give much more detailed information such as the flexibility or 
subunit arrangement of proteins within the system [143]. 
Information provided by the small angle scattering techniques have been used to study 
the quality of the protein fold, including estimation of secondary structure levels [144]. 
This has been used to monitor the effect of pH on the conformational state of bovine 
serum albumin and the resulting protein-protein interactions that take place [145]. 
Experiments on dynamic systems such as protein folding have been shown to yield 
accurate results when compared to complimentary techniques such as tryptophan 
fluorescence and circular dichroism, where the formation of the globular protein is 
monitored [146].  
There are further examples of how beamline small angle scattering can be used to take 
measurements on dynamic systems, owing to the short time period it takes for a single 
scattering pattern to be obtained. This was utilised using SAXS by M.Kataoka et al. to 
monitor the radius of gyration of cytochrome C over time to study the compactness of 
the protein as it passes through the molten globule state [147]. More relevantly this 
technique has also been used to monitor the dynamic aggregation of BSA after breakage 
of the disulphide bond [148]. In this early experiment however, the appearance of 
aggregation was sufficient, and a quantitative examination of the data was not 
undertaken. 
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Static samples of aggregates have additionally been monitored using this technique, 
such as aggregates of amyloid β-protein, where the number of molecules that form an 
aggregate, and their hydrodynamic radius were uncovered [149]. The aggregation of 
staphylococcal nuclease has been probed under small angle scattering, coupled with 
FTIR and circular dichroism to understand the transitions in structure that occur during 
aggregation [100]. More recently, the heat induced aggregation of β-lactoglobulin was 
studied in order to understand the nucleation phase of aggregation [150]. This allowed 
the initial nuclei shapes of tetramers and cyclic clusters to be elucidated.  
2.4 Proteins 
This section will cover the proteins utilised in these experiments and the relevant 
literature in the field of aggregation and refolding, depending on their use in 
experiments within this project. 
2.4.1 Bovine Serum Albumin 
 
Figure 2.10: Structure of BSA molecule. PDB code 3V03 [1]. 
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BSA is a 66kDa serum protein present in cows. Its structure has recently been solved 
(PDB code 3V03) [1], it consists of 583 amino acids and contains a largely helical α-
helical structure. Due to the ease of obtaining the protein from cow serum; and its 
relative low cost, BSA is used as a standard in many protein assays and also used in 
protein aggregation studies (Figure 2.10) 
When subjected to a temperature of 70 ºC or above, it is seen that there is a change in 
secondary structure content with an increase in the quantity of β-sheet structure whilst 
the quantity of α-helices decreases. Above 70 ºC the formation of β-sheets is 
irreversible [151]. The self association interactions occur through the non-native, more 
open domain I of neighbouring molecules. It is this initial structural change which is the 
initiating step for aggregation [152]. Additionally the amount of β-sheet content formed 
and the amount of aggregates increase as the protein environment is more distant from 
the isoelectric point [90]. This secondary structure formation may be altered by the 
presence of metal ions in the solution [153], however it does not affect the propensity of 
the molecules to aggregate. 
2.4.2 β-Lactoglobulin 
 
Figure 2.11: Crystal structure of β-lactoglobluin. PDB code 3NPO [1]. 
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β-lactoglobulin is an 18kDa protein which consists mostly of β-sheets (PDB code 
3NPO) [1]. It is present in the milk of cows, and as with BSA, due to the ease in 
isolating large quantities of the protein, it is often used in folding and aggregation 
studies, in addition to use as a standard in protein assays (Figure 2.11). 
The thermal aggregation of β-lactoglobulin is a rapid process, due to the high 
hydrophobic nature of the residues within the protein. The thermal unfolding of the 
molecule has been shown to be immediately followed by aggregation of the monomer 
[154]. In later studies it was elucidated that the lactoglobulin protein undergoes a slight 
structural arrangement before the aggregation is seen to occur [155]. This appears to 
agree with early work that suggests that the β-strands present in lactoglobulin are 
transformed to antiparallel β-sheeets before aggregation [156]. The monomers associate 
through a combination of hydrophobic and disulphide interactions. Additionally, the 
levels of secondary structure present within the aggregate molecules can also be 
dependent on concentration, with higher concentrations leading to a larger proportion of 
secondary structure remaining [157]. This appears to be a stability conferred by the 
presence of other native protein molecules. 
There has been some interest in the refolding of β-lactoglobulin as during folding, there 
is an α-helical intermediate present, before the formation of the native β-strand protein 
[158]. The transformation to native β structure occurs in the late stages of the folding, 
although there is a significant amount of β-sheet already present within the intermediate 
[159] . 
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2.4.3 Myoglobin 
 
Figure 2.12: Crystal structure of myoglobin. PDB code 1MBN [1]. 
Myoglobin is an 18kDa protein which consists of many α-helices. Myoglobin is 153 
residues in length and is an oxygen carrying protein which exists in the muscle, 
including the heart [1, 160] Figure 2.12. 
Early studies of myoglobin showed that there is a decrease in α-helical content when the 
protein is solubilised in water [161] therefore the molecule may be less stable than the 
native. More recent aggregation studies have identified the presence of an aggregation 
prone intermediate which retains the core structure of the myoglobin molecule, 
resembling the early folding intermediate [162]. Additionally, this paper showed that 
there is a formation of β-sheets when the protein tends to aggregate at it is in conditions 
away from the isoelectric point, which is comparable with studies seen on other proteins 
mentioned here. When the aggregates of myoglobin are formed at a low temperature (50 
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ºC), there is a large quantity of the native structure still present within the aggregate 
subunits, however the process is irreversible [163]. 
During refolding of myoglobin the protein has a tendency to form a non native dimer 
with exposed hydrophobic residues [164]. Secondary structure formation takes place in 
two stages which appear to form at different rates [165]. The initial stage is the 
formation of around 40 % of the secondary structure whereupon the remaining 
secondary and tertiary structure assemble around in the second stage. Here the molten 
globule state of myoglobin may exist [166].  Succeeding this, minor structural 
rearrangement results in the final native structure. 
2.4.4 Cytochrome C 
 
Figure 2.13: Cytochrome C crystal structure. PDB code 3CYT [1]. 
Cytochrome C is an electron carrying protein found in cells for production of ATP [1]. 
It is 24kDa in size and contains a secondary structure which consists solely of α-helices 
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(Figure 2.13). Folding of cytochrome C involves formation of the protein structure 
around the heme molecule, within 1 millisecond of initiating folding the structure of 
cytochrome C can be collapsed around the heme moiety [167]. The heme is not thought 
to determine the folding behaviour of cytochrome C, which is driven through protein-
protein interactions [168]. Rapid rearrangement of exposed side groups follows to 
achieve energetically favourable conformations. Whilst in this molten globule state 
cytochrome C has also been shown capable of dimerising [169], whilst partially folded 
states of cytochrome C are the most likely to be aggregate prone [167]  
2.4.5 Ribonuclease A 
 
Figure 2.14: Crystal structure of ribonuclease. PDB code 5RSA [1]. 
Ribonuclease A is one enzyme responsible for degrading RNA. It consists of 124 amino 
acids and is 13.8kDa in size. It consists of both α-helices and β-sheets and is a very 
stable molecule (Figure 2.14). Ribonuclease was one of the first proteins used in folding 
studies [170], where amino acid sequence was shown to determine the folded structure 
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of the protein. During folding ribonuclease forms a number of intermediates which 
utilises at least 2 disulphide bonds to retain proximity of separate sections of the amino 
acid chain to complete folding [171]. 
2.4.6 Summary 
The proteins used here for both aggregation and refolding experiments are model 
proteins in their respective fields. They represent a cross section of secondary structural 
contents, and isoelectric points. During experimentation this will allow for any 
contributing effect of starting structure, or properties, to be contrasted. In refolding 
experiments, proteins with a lack or (or minimal) disulphide bonds were favoured in 
order to achieve the most highly unfolded state possible, without using reductants and 
oxidants to moderate these bonds.  
Using this range of proteins, generic questions relating to aggregation could be asked, 
with the varied systems representing general trends of all proteins: 
a) How does particulate aggregate nucleation occur? Is it as simple as suggested 
from microscopy studies by Krebs et al.(2.3.4)? 
b) Does the model for particulate aggregate growth (2.3.4) agree with dynamic 
measurements of the model proteins aggregating? Is it possible to elucidate 
kinetic and thermodynamic values for this process? 
c) Does the mobility of a protein monomer affect its propensity to aggregate? How 
mobile must a protein be to form aggregates? 
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Chapter 3 : Theory 
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3.1 Introduction 
This chapter contains details of the experimental techniques carried out on this project 
coupled with a justification for their use and underpinning theory. The techniques 
included here are: fluorescence anisotropy, small angle neutron scattering and ultra 
violet light scattering spectroscopy. 
3.2 Fluorescence Anisotropy 
Fluorescence anisotropy uses polarised light to probe the rotational motion of protein 
fluorophore side groups. The protein is subjected to light polarised in the vertical plane, 
before the emission of horizontally polarised light from the protein is measured. This 
technique can be used to monitor whether fluorescent side chains are compact within 
the protein or exposed and mobile. Compaction of side chains is one of the latter stages 
in the protein folding process [1] therefore this technique will indicate the extent of 
mobility present in the latter stages of the structural arrangement. 
Fluorophores will only absorb light at specific wavelengths. In respect to protein 
fluorophores, there are two main residues; tryptophan and tyrosine. These two have 
separate peak absorbances at different wavelengths; the optimum for tyrosine is 276 nm, 
whilst for tryptophan it is 280 nm [2]. The overall range over which these absorb 
overlap, but selecting a wavelength greater than 276 nm will excite almost exclusively 
the tryptophan residues. This property is desirable as the tryptophan is a hydrophobic 
residue, therefore when the protein is in its folded state it will be buried inside the 
hydrophobic core of the protein and therefore is less mobile. An additional useful 
characteristic of probing for this residue is seen by the fact that tryptophan fluorescence 
is shifted by up to 20 nm when buried within the protein as compared to on the surface 
of a protein [3], which can be studied directly by fluorescence spectroscopy. 
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When the vertically polarised excitation light strikes the protein sample, only the 
fluorophores situated in the same plane as that of the light beam will absorb photons [4]. 
There is a significant period of time between the photon of light being absorbed by the 
fluorophore, and a photon being emitted at a larger wavelength. During this period of 
time, if there is movement within the protein fluorophore, it will alter the plane in which 
the emitted photon is released. If there is no movement within the side group, the 
photon will be emitted in the same plane in which it was excited, in this case the vertical 
plane.  
 
Figure 3.1: Planes of polarisation for beam excitation and emission detection within the fluoresence anisotropy setup 
The fluorescence anisotropy setup utilises two photomultipliers (Figure 3.1), a separate 
photomultiplier for detecting the individual planes: vertically, and horizontally polarised 
light [5]. This allows for detection of the light emitted in the same plane as the 
excitation beam, and light whose polarisation has been changed through mobility of the 
tryptophan residues. This is the basis of the fluorescence anisotropy theory used to 
study the structural aspects of the protein. The fluorescence anisotropy is calculated 
using Equation 3.1; 
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Equation 3.1: Defining fluorescence anisotropy   
Where the fluorescence anisotropy r is calculated from: Iv; the fluorescence intensity of 
the vertically polarised emission and IH ; the fluorescence intensity of the horizontally 
polarised emission. This ratio gives an anisotropy value, where higher values of r relate 
to a more stable fluorophore, and lower r values relate to fluorophores which are more 
mobile [6]. This can be read on the millisecond timescale, therefore hundreds of 
readings can be taken over the course of a second, and these measurements are taken for 
many minutes, which is ideal for both the rapid dynamic process and the slower 
structural rearrangements that are seen in protein folding. 
3.3 Small Angle Scattering 
There is a large amount of literature present on the theory and principles behind small 
angle scattering [7-10]. This section aims to cover an overview of the general theories 
can be applied within this work on proteins and protein aggregates. 
Neutrons are uncharged particles with a mass of 1.678×10
-24
g and a spin of ½. The 
uncharged nature of the neutron allows it to interact deep within the scattering matter, 
with the nuclei of atoms through the strong nuclear force [7].  The spin of the neutron 
allows it to be used to probe magnetic properties of the scattering structure, however 
this use in not covered within this body of work.  
Unlike X-rays which have energies of around 10keV, neutrons have energies of around 
10meV. This difference in properties means that when X-rays are scattered there is a 
minimal energy change, however inelastic scattering of neutrons delivers a measurable 
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change in energies. The use of the small angle techniques here covers only the elastic 
scattering from the particles. 
 The strength with which each atom scatters the neutron does not vary linearly with 
atomic number (Figure 3.2). The nucleus of an atom occupies only a fraction of the total 
atom volume, therefore the majority of neutrons may pass through without interaction. 
Therefore a large number of neutrons are required to produce significant measurable 
interaction with the matter. For this reason, large scale facilities are required to produce 
the flux of neutrons capable of creating measurable data sets within a satisfactory 
timescale. Thermal neutrons are used in small angle experiments and generally have a 
wavelength of between 1-6 Å. This length scale is of similar magnitude to the 
separation distance between atoms in matter, and so is ideal to probe detailed structure. 
 
 
Figure 3.2: Scattering length value against atomic number. Values include isotopes.[11] 
 Neutrons are produced either by nuclear fission in a reactor or spallation. Examples of 
both are methods of production at large scale sources are; the Instituit Laue-
Langevin,(ILL) in Grenoble, France as a source of neutrons provided by fission and 
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ISIS at the Rutherfod Appleton Laboratory, Oxfordshire, UK for neutrons produced by 
spallation. 
In a spallation facility, protons are extracted from a hydrogen plasma source and 
accelerated by a linear accelerator into a larger circuit of bending magnets. Here, the 
bending magnets accelerate the ions to 70 MeV before being directed towards a heavy 
metal target. The nuclei in the atoms of the heavy metal target can absorb protons which 
will result in each nuclei emitting a neutron. Neutrons emitted by the target are slowed 
by moderators in order to achieve a suitable wavelength i.e thermal neutrons with a 
wavelength around the size of 1 Å.  
Nuclear fission facilities work from the fission of a radioactive element such as uranium 
235. Within the nuclear reactor, the uranium undergoes radioactive decay releasing 
neutrons which propagate the further decay of the isotope. The fission process is 
mediated through the use of boron control rods which absorb neutrons to limit the 
propagation of the radioactive decay. As in spallation, the neutrons emitted from the 
reactor are slowed by moderators in order to obtain thermal neutrons of useable energy.  
Small angle scattering equipment is designed to treat the flow of photons or neutrons in 
order to maximise the flux at the sample whilst maintaining accuracy in the beam in 
order to correctly calculate the scattering angle, 2θ. This essentially involves removing 
any divergence from the beam by passing the beam through collimation and ensuring 
the desired wavelength and size of the beam is directed onto the sample (Figure 3.3).  
As small angle scattering probes length scales of matter in the range of above 10 Å, we 
can see using Braggs law [12] that the scattering from the beam will be present at a low 
angle near to the un-scattered beam (Equation 3.2). 
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Equation 3.2: Braggs law 
Where d represents the repetitive length scales within the structure. As the angles at 
which the scattering is detected are so low, it is imperative that there is no divergence 
from the beam; which would mask the scattering produced from the sample and 
therefore collimation is of great importance. This further shows why such high flux 
sources are required for these experiments as the accurate collimation reduces the 
intensity of the beam. 
The scattered beam which hits the detector is produced from the volume of the sample 
which is irradiated by the beam. The scattering is a result of variations in the “density” 
of the sample. As X-rays and neutrons are scattered from different components of the 
atom, these “density” attributes vary between SAXS and SANS techniques, allowing 
each to probe different features of the structure. The scattering length density is 
responsible for neutron scattering. 
 
 
 
 
In small angle scattering, some assumptions are applied to the scattering from the 
sample in order to extract information from the scattering pattern. The first is that the 
sample is of a low enough concentration that the scattered beam is the product of a 
single scattering interaction, and that none of the beam is scattered from multiple 
scattering points. The second is that there is neither a gain nor loss in the frequency in 
θ 
Detector Scattered beam Sample Collimated 
monochromatic beam 
 
Direct beam 
Figure 3.3: Overview of a scattering experiment. 
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the beam i.e the scattering is elastic, and that the incident beam suffers no distortion 
from the sample. 
Examining Figure 3.4, it can be seen that the scattered neutrons at wave vector ks 
originating from beam ki (of which the majority of neutrons pass through the scattering 
medium) land on the detector at solid angle dΩ. Figure 3.5 and Equation 3.3 illustrate 
how the scattering vector, q can be ascertained from this. Models of the neutron 
scattering are given as a function of q. 
 
Figure 3.4: The scattering geometry of a SANS experiment. A detector at solid angle dΩ counts the number of 
neutrons scattered. Adapted from [9]. 
 
Figure 3.5: Vector diagram for calculation of scattering vector [9]. 
90 
 
         
Figure 3.6: Equation for definition of q vector. 
The distribution of the scattering, as measured on the detector, is given in terms of the 
scattering vector q, which relates both the wavelength λ of the incident beam, and the 
scattering angle by Equation 3.3. 
  
  
 
    
 
 
Equation 3.3: Definition of the scattering vector 
The scattering intensity measured from the detector can be related by the sum of the 
scattering from individual particles which are a product of scattering length; the 
distribution of material within a particle, and the phase factor determined by the 
position of the particle in the sample. 
The instrument used in these experiments was D22 at the ILL. This is a small angle 
neutron scattering station which is designed for the study of biological macromolecules. 
Due to the large amount of flux (1.2×10
8
 n cm
-2
 s
-1 
at the sample) produced by the 
reactor and the 55x40 mm beam cross section, it is ideal for studying dynamic samples. 
The wavelength range it is available to select is between 4.5-40 Å. Detector distance can 
range from 1.4 m to 17.6 m, and the detector has an area of 102.4 cm by 98 cm, 
allowing for a large q scale to be obtained (4×10
-4
 Å
-1 
to 0.44 A
-1
). Pixels on the 
detector are 8x8 mm in size which allows for a high resolution in q vector to be studied.  
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Figure 3.7: Diagram of D22 instrument small angle neutron scattering beamline [13] 
The scattering from a solution; I(q), can be described in terms of both the form factor 
P(q); describing the shape of the particles, and the structure factor S(q); describing the 
scattering arising from the interactions between these particles (Equation 3.4) .  
 ( )   (  )    ( ) ( ) 
Equation 3.4: Model of the total scattering from a solution. 
Where Δρ is the difference in scattering length density between the protein and the 
surrounding medium (buffer) and υ is the volume of sample illuminated by the beam. In 
this study of protein aggregates, the concentrations were kept low enough so that the 
effect of structure factor was negligible (any scattering arising from this would be inside 
the beamstop) therefore S(q)=1. 
This can be simplified for dilute solutions as the position of the scatterer within the 
sample can be anywhere and is unaffected by the position of other particles and in the 
dilute system the average scattered intensity is the sum of the averaged intensities by the 
scattered particles. For identical particles the scattering can be calculated solely as the 
form factor P(q) of the particles. 
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As the scattering produced on the detector is a result of all matter in the path of the 
beam, i.e the sample holder and the buffer, it is required to make background 
subtractions in order to analyse solely the scattering coming from the sample. This is 
simply performed by measuring the sample cuvette and buffer for the same period of 
time as the sample, and performing a subtraction of the resultant I versus q plots.  
Alternatively the intensity from background samples can be scaled to match the 
intensities of the sample plots at high q, where there is no contribution of scattering 
from the sample. 
The scattering length density ρ, of the protein is calculated from bi (Equation 3.5); the 
coherent scattering length of the individual atoms, which can be seen in Figure 3.2. 
  
∑      
 
 
Equation 3.5: Scattering length density calculation. 
Where i is the number of identical atoms, x the number of atoms, and v the molecular 
volume of the protein [14]. This can also be calculated experimentally by monitoring 
the scattering from a protein in solutions with different H2O:D2O ratios. These solutions 
would have a known scattering length density (SLD), therefore the SLD of the protein 
could be obtained. This scattering length is not dependant on the wavelength of the 
scattering neutrons. For the scattering length of electrons the scattering length bi can be 
substituted for scattering length of the number of electrons within the atom, therefore 
this value increases with increasing size of the atom. The scattering lengths of 
individual atoms for both neutrons and electrons are well documented [15].  
For the homogenous spheres of radius R, the form factor P(q) can be related to 
scattering vector by Equation 3.6. 
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Equation 3.6: Rayleigh scattering form factor for a sphere [16] 
 
Taking these known equations for the form factor of a sphere, a novel equation can be 
created for aggregates. In the case of the protein aggregate system, there are two 
populations of spheres; the large aggregates and the monomer. In order to model the 
form factor of this, the volume and concentration of the monomer have to be taken into 
account, and also these same values for the aggregate (these had to be expressed as a 
product of the two for fitting purposes, as neither value is known). 
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Equation 3.7: Form factor of two sphere populations 
Where Vm and Va are the volumes of monomer and aggregate respectively, Cm and Ca 
are the volume fractions of both the aggregate and the monomer and Rm and Ra the radii. 
The form factor of any homogenous particle can be estimated by assuming it to be made 
up of a number of small spherical particles. Using the form factor for a particle made up 
of spherical objects, which is averaged over all orientations in three dimensional space, 
the form factor can be expressed by the Guinier approximation (Equation 3.8): 
 ( )     [ 
     
 
] 
Equation 3.8: Guinier equation 
This is the Guinier approximation which gives a well defined measure of the object 
scattering [17]. This is defined in terms of the radius of gyration Rg, which describes the 
mean square mass distribution around its centre. The mean square radius of gyration 
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must be obtained from the scattering coming from low q (where q×Rg <1.3), as 
Equation 3.8 is an approximation of a Taylor series expansion where it is assumed q is 
very small (< 0.003 Å
-1
).  Furthermore, as the Guinier approximation is based on only 
the particle scattering, the sample must be sufficiently dilute as to not introduce inter 
particle scattering. 
 
Figure 3.8: Accuracy of the Guinier approximation for scattering from dilute homogenous spheres. Values depend on 
normalisation and length scales, separation between the two plots begins at approximately q×Rg =1.3. 
Additionally, for a sphere, the Rg can be related to the radius; R by Equation 3.9. 
   √
 
 
  
Equation 3.9: Relationship between radius of gyration for a sphere and physical radius. 
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Figure 3.9: Illustration of Kratky plots for protein in different conformations from folded to unfolded. Adapted from 
[18] 
Kratky plots offer a qualitative measure of the relative extent of folding or unfolding 
present within a protein sample (Figure 3.9). This is seen in the scattering as a small 
change and the small length scales and so is seen as a deviation in the scattering at the 
large q region. This change is small on the plot of I versus q, therefore using a Kratky 
plot of q
2
I versus q will exaggerate any deviations seen at the higher q value. For a 
folded protein, there is a well defined peak in the Kratky plot (Figure 3.9) As the extent 
of unfolding within the protein increases, this peak will become less prominent as the 
intensity at high q increases. An unfolded protein will show no peak on a Kratky plot 
[18]. The Kratky plot measures the degree to which a molecule is compact, therefore it 
may not be able to differentiate between native and non-native protein conformations if 
they are equally compact. 
The Porod law shows that for a sharp interface the intensity from scattering should 
decrease as q
-4
 for large q [8] (Equation 3.10), where S is the surface area of the matter 
and V the volume. 
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Equation 3.10: Porod Equation 
Equation 3.10 is limited to large q values, which can extend to infinity as the length 
scales from which the scattering occurs are uncorrelated to any other surface. This also 
holds for concentrated systems, as at large q it is only dealing with the surface of the 
particle. As the scattering intensity from a sphere is seen to decrease as q
-4
, as is a thin 
rod at q
-3
 and a thin disk at q
-2 
[7]. 
In irregular shapes, this value can be considered as a fractal dimension, where values in 
the range between 1 and 3, the larger the value the more compact the structure is. At 
lower q values  it is also possible to see evidence of surface fractals, where the 
scattering decrease is seen to occur at values between 2 and 3. A value of 2 represents a 
completely smooth surface, whereas a value of 3 would represent a totally rough, folded 
surface. 
3.4 Ultra Violet Light Scattering Spectroscopy (UVLSS) 
UVLSS is used to characterise the size of particles in the range of 50-1000 nm. Unlike 
either dynamic or static light scattering this technique utilises a range of wavelengths to 
determine the size of the particles. 
Ultraviolet light backscattering intensity versus wavelength follows a power law 
(Equation 3.11). 
     ( ) 
Equation 3.11: Relationship between back scattered intensity and particle diameter. 
Equation 3.11 illustrates the wavelength dependence of the scattering is relative to the 
size of the particle scattering. Is is the back scattered intensity, λ the wavelength and 
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β(d) is the scattering exponent which is a function of the diameter, d. The relationship 
between β and d is covered by Mie theory [19], which determines the scattering from a 
single population of particle sizes within the sample. This generally requires that the 
sample be thin and of low concentration in order to prevent multiple scattering from 
occurring. However in a system such as the dynamic aggregation of proteins as studied 
here, such conditions are not possible where concentrated systems are required to 
instigate the protein aggregate formation. It has been shown though, that single 
scattering events can be calculated from multiple forward scattering values at 
absorbance values below 4.3 [20]. Therefore by monitoring the forward scattering 
across a range of wavelengths, it is possible to elucidate the size of protein aggregates 
over a time period. 
In order to relate the experimentally obtained scattering exponent to a particle size, both 
the refractive index of the protein and of the solution is required. These values are 
wavelength dependent, and therefore refractive index value for the protein at each 
wavelength in the range is required. To calculate the refractive index for the protein, the 
Lorentz-Lorenz molar refraction [21] was used to sum the contributions to the refractive 
index from all residues and bonds within the molecule. 
Table 3.1 (overleaf) lists the values used to calculate the refractive index of the protein 
for a series of wavelengths. 
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Table 3.1: Refractive increments for the amino acids and bonds present in the protein 
Residue 
Refractive increments for wavelength /cm
3
 mol
-1
 
656.3 486.1 434.0 589.3 
Glycine 1.092 1.115 1.121 1.100 
Alanine 5.689 5.783 5.832 5.718 
Valine 14.883 15.119 15.254 14.954 
Leucine 19.480 19.787 19.965 19.572 
Isolecine 19.480 19.787 19.965 19.572 
Phenylalanine 29.593 30.343 30.788 29.825 
Proline 13.791 14.004 14.133 13.854 
Methionine 22.573 22.809 22.944 22.644 
Aspartic Acid 13.499 13.819 13.991 13.605 
Lysine 23.973 24.385 24.575 24.094 
Glutamic Acid 18.096 18.487 18.702 18.223 
Arginine 30.615 31.337 31.589 30.831 
Serine 7.211 7.311 7.369 7.243 
Asparagine 13.692 13.950 14.057 13.769 
Cysteine 13.379 13.473 13.522 13.408 
Threonine 11.808 11.979 12.080 11.861 
Glutamine 19.975 20.442 20.654 20.120 
Tryptophan 41.361 42.546 43.183 41.729 
Tyrosine 31.115 31.871 32.325 31.350 
Histidine 24.862 25.595 25.879 25.080 
Backbone 
groups 13.363 13.740 13.897 13.482 
N and C 
terminus 11.709 11.925 12.004 11.776 
Water 3.706 3.758 3.779 3.725 
 
The Lorentz-Lorenz molar refraction of the entire protein molecule RLL can then be 
calculated as the sum of the molar refraction from individual residues Ri. 
    ∑   
Equation 3.12: Lorentz-Lorenz summation 
The RLL value can then be related to the refractive index of the protein using the 
following equation. 
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Equation 3.13: Lorentz-Lorenz molar refraction equation. 
Where M is the molecular weight of the protein (g/mol) and r is the density of the 
molecule (g/cm
3
) and n is the refractive index. 
The density of the protein was calculated using structural information from the Protein 
Data Bank [22] 
  
  
   
 
Equation 3.14: Density equation for proteins 
Where An represents Avogadro’s number, Mw is the molecular weight of the protein and 
V is the volume calculated using VADAR [23]. VADAR is a web service which takes 
the structural information of the protein from the PDB and calculates the volume of the 
molecule based on the position and angles of the residues within the protein. Below are 
listed the values for the volumes of proteins using VADAR. 
Protein PDB Accession Number Volume Å3 
BSA 3V03 86654.65 
β-lactoglobulin 1CJ5 21017.68 
Horse heart myoglobin 1YMB 20876.5 
Table 3.2: Volumes of protein calculated in VADAR. 
The refractive index of each protein across a range of wavelengths was then determined. 
From this a plot of refractive index relative to wavelength can be made, and the Cauchy 
equation can be fitted to it [21]. The simplified form of the Cauchy equation shows: 
     
  
  
 
Equation 3.15: Cauchy equation 
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Equation 3.15 shows that a plot of n versus 1/λ2 would give a straight line whose 
equation can be used to calculate the value of the refractive index at each wavelength in 
the range. 
 
Figure 3.10 Wavelength dependence of refractive indices of candidate proteins. Β-lactoglobulin and BSA show 
barely any difference at each wavelength value, but a slight difference in best fit lines. Β-lactoglobulin best fit line is 
indicated by the dotted line. 
Values for the refractive indices of water were obtained from the International 
Association for the Properties of Water and Steam, with the data obtained for water at 
20 ºC [24]. Furthermore this paper illustrates that the refractive index of water barely 
changes with increasing temperature, which is applicable to the methods described here. 
This can also be assumed to be the case for the protein over the same temperature range 
[25]. 
The refractive indices of the protein and the solution could now be used to populate a 
programme to calculate the values for the Mie theory solution to light scattering for a 
range of sphere sizes. The programme used is an adapted version of the programme 
CALLBHMIE [26]. This programme takes the values of the refractive index of the 
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protein, the medium, the wavelengths and the size of the spheres in a text file, and 
calculates the extinction efficiency for each value. The wavelengths covered the range 
used in the UVLSS experiments, depending on which protein was used, and the sphere 
range covered a size of 10-1000 nm. The programme then populated a text output file 
with values for extinction efficiency for each combination of wavelength and sphere 
size. 
Extinction efficiency Qext, is related to the absorbance A by Equation 3.16, where ρ is 
the number of particles per unit volume and Ɩ is the sample pathlength with   being the 
sphere radius. 
  
         
  (  )
 
Equation 3.16: Extinction efficiency equation [27] 
Therefore, as the extinction efficiency is directly related to the absorbance, the 
theoretical scattering exponent can be obtained directly from the output of the 
CALLBHMIE programme. This allows for the theoretical sphere size to be related to 
the scattering exponent. 
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Figure 3.11: Theoretical diameter against scattering exponent for β-lactoglobulin. 
A sixth order polynomial is fit to this graph (Figure 3.11) which gives a large R
2
 value 
(>0.95) for each protein despite the deviation at low diameters. This has also shown 
good correlations with data obtained in the later sections. The fit within this plot is a 
sixth order polynomial which gives an equation to convert between sphere diameter and 
the scattering exponent β.  
This theory relies on some assumptions, those mentioned here are addressed and related 
to the literature to show that they are fair. Further included in this theory is that the 
calculation of the number of monomers in an aggregate does not take into account and 
hydration levels within the aggregate. This may be a limitation of the technique 
mentioned here, however this may be improved by using the hydration levels of 
aggregates created by SANS experiment 
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Chapter 4 : Methods and Materials 
4.1 Ultra Violet Light Scattering Spectroscopy 
Protein Solutions 
Protein samples for both absorbance measurements and refolding experiments were 
made up similarly, but in separate buffers depending on application. Lyophilized protein 
samples were purchased from Sigma-Aldrich Co. and weighed out using a Precisa 120A 
4 figure balance, and dissolved in the appropriate buffer. The protein samples and their 
supplier details are listed in Table 4.1. 
Table 4.1:Table of studied proteins with associated details 
Protein Details Sourced From Product Code 
Bovine Serum 
Albumin 
Fravtion V approx 99 % Sigma H3059-109 
Β-Lactoglobulin From Bovine Milk 90 % Sigma L3908 
Myoglobin From Equine Heart Sigma M1882 
 
Buffers 
For UVLSS protein aggregation experiments, a sodium phosphate based buffer, also 
containing sodium chloride, was made. The sodium phosphate buffer contains two 
elements; sodium phosphate monobasic (NaH2PO4), and sodium phosphate dibasic 
(Na2HPO4). These two elements have pH values of 5 and 10 respectively; therefore a 
combination of the two will result in a buffer of a pH between these values, depending 
on the proportions. Approximate volume values are given for the different pH buffers 
created. The purpose of the sodium chloride was to ensure that the protein aggregation 
occurred over a temperature range that could be performed within the experimental 
setup, as sufficient levels of  sodium chloride increases a proteins propensity to 
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aggregate. The advantage of this buffer is that multiple pH ranges can be probed whilst 
the surrounding environment remains constant across experiments. The following buffer 
was assembled: 
Table 4.2:Components of sodium phosphate buffer complete with sourcing details 
Buffer Components Details Sourced From Product Code 
Sodium 
Phosphate Buffer 
100 mM 
NaH2PO4 
Sodium 
Phosphate 
Monobasic 
Sigma S0751 
100 mM 
Na2HPO4 
Sodium 
Phosphate 
Dibasic 
Sigma S0876 
100 mM NaCl 
+80 %, reagent 
grade ≥ 98 % 
Sigma 310166 
 
Table 4.3:Approximate volumes of constituents for 1L sodium phosphate buffer. 
pH 
Volume 
NaH2PO4 
Volume 
Na2HPO4 
5.4 20 980 
5.8 80 920 
7.2 680 320 
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These reagents were dissolved in ultrapure water from the ELGA UHQ-PS Ultra pure 
water system, and the pH adjusted through the use of a SCHOTT probe to monitor the 
pH, adjusting the amount of each buffer component to obtain the desired pH. 
UVLSS procedures 
Absorbance spectra were obtained from the protein samples using a Shimadzu UV-1601 
spectrophotometer between 320 nm and 420 nm for bovine serum albumin and β-
lactoglobulin. Myoglobin, due to its red/brown colour absorbs light at these 
wavelengths, and therefore the aggregation was measured between 700-800 nm, which 
is still capable of monitoring aggregate growth. The protein samples were placed in a 
UV 10mm light path Hellma macro silica cuvette with a volume of 3.3 mL (Figure 4.1).  
The temperature of both the sample and the reference chamber was controlled through 
the use of a water heated temperature block, connected to a Grant GD150 5L water 
bath. These were connected using reinforced rubber tubing, and secured in place using 
jubilee clips around entry and exit nozzles. This set up allowed the protein sample to be 
heated from an initial 25 ˚C to approximately 95 ˚C. The temperature was monitored 
using a platinum HEL-705 RTD temperature sensor integrated into the rubber cuvette 
lid. This was calibrated so that it was sufficiently submerged in the sample to give an 
accurate temperature whilst not entering the window for UV absorbance measurement. 
This temperature sensor was then wired to a Pico PT100 data logger. Both this device 
and the spectrophotometer were connected to a PC that ran the Shimadzu UVProbe, 
Pico picolog PLW recorder, and Grant Labwise 1.0 water bath control software to 
enable data collection, and remote programming of the water bath temperature stages.  
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Figure 4.1:Sample setup for UVLSS inside a water bath controlled heating block. 
The spectra were recorded between 420 nm and 320 nm at a medium scan rate, an entire 
scan taking 13.3 seconds to complete. UV probe software allowed for 100 scans to be 
taken when performing isothermal runs, before requiring a reset to continue 
measurement. To accommodate this; the scan intervals were adjusted according to the 
temperature being measured, in order obtain sufficient spectra to properly characterise 
the aggregate growth. 
Between experimental runs, the protein sample and cuvette required meticulous 
cleaning to ensure no protein aggregate remained within the equipment. This was 
performed by rinsing with hot water, then soaking the equipment in hot detergent 
(Decon-90) this was then followed by rinsing with deionised water, and allowing the 
equipment to dry in ambient conditions. 
Protein concentration: After initial sample preparation, the Shimadzu 
spectrophotometer was used to measure the protein absorbance at a single wavelength at 
280 nm, to ensure the protein concentration was consistent between protein samples.  
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Temperature ramp: In order to ascertain the temperature range over which a protein 
aggregates, temperature ramp measurements were run. The Grant water bath control 
Labwise 1.0 was used to program a temperature ramp that would relate to a heating rate 
such as 0.1
 ˚C/min. The Pico data logging software picolog PLW recorder was used to 
monitor the temperature within the cell at set time intervals, identical to that of the scan 
intervals from the Shimadzu. UV probe was utilised to give an absorbance value at 320 
nm at set time intervals in “Kinetics” mode. These pieces of recording software were 
initiated simultaneously in order to relate the absorbance and temperature values. 
Isothermal spectra: Isothermal spectra were collected using the “Spectrum” mode on 
the UV probe software. This recorded the sample cells absorbance between 320 nm and 
420 nm at set time intervals.  The Pico data logger was set to measure the temperature 
within the cuvette at time intervals equal to that of the intervals on the 
spectrophotometer. Each run started at 25 ˚C and was ramped up to the desired 
temperature at the heating rate of 2 ˚C/min.  
4.2 Stopped Flow Refolding 
The following section details the methods used for measurements of fluorescence 
anisotropy, absorbance a hydrophobic probe fluorescence of protein refolding in a 
stopped flow system. 
Solutions 
In protein refolding experiments of proteins listed in Table 4.4, the proteins were 
unfolded in 8 M urea (reagent grade 98 %, Sigma s30498-448) made up with ultra pure 
water. 
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Table 4.4:Refolding protein information complete with sourcing details. 
Protein Details Source 
Product 
Code 
Cytochrome 
C 
From bovine heart heart ≥95 % based on molecular 
weight 
Sigma C2037 
β-
lactoglobulin 
From bovine milk ≥90% from PAGE Sigma L3908 
α-
lactalbumin 
From bovine milk type III, calcium depleted ≥85 % from 
PAGE 
Sigma L6010 
Ribonuclease 
A 
From bovine pancrease type 1-A 20-100 Kunitz 
units/mg 
Sigma R5503 
 
Each protein required an individual buffer to obtain a high standard of protein folding. 
The refolding buffer used in for each protein refolding experiment is listed in Table 4.5. 
Refolding buffers vary depending on the properties of the protein to be refolded. Most 
proteins require a favourable pH to aid refolding, additionally; some proteins require a 
salt concentration for to prevent aggregation. Cytochrome C aggregation assays are also 
performed with additional NaCl present within the buffer. In experiments where salt is 
present in the buffer this is stated. The constituents of each buffer are listed in Table 4.6, 
where the sodium phosphate buffer make up is identical to that stated in the UVLSS 
method section (Table 4.2). 
Table 4.5:Refolding proteins complete with buffer pH and components 
Protein pH Components 
Cytochrome C 10.6 100 mM Tris 
β-lactoglobulin 7.8 100 mM Tris, 10 mM NaCl 
α-lactalbumin 7.8 100 mM Tris, 1 0mM NaCl 
Ribonuclease A 7.8 100 mM NaPO4, 20 mM NaCl 
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Table 4.6: Buffer components and sourcing details. 
Components Details 
Sourced 
From 
Product 
Code 
Tris ACS Regenz Sigma 
S87203-
289 
NaH2PO4 
Sodium Phosphate 
Monobasic 
Sigma S0751 
Na2HPO4 Sodium Phosphate Dibasic Sigma S0876 
NaCl 
+80 %, reagent grade ≥ 98 
% 
Sigma 310166 
 
Anisotropy Procedures 
The stopped-flow fluorescence anisotropy measurements were taken using the Applied 
Photophysics SX-20 stopped flow fluorescence anisotropy instrument. This set up 
includes the power supply, bulb housing, beam width control, light polariser, sample 
cell, photomultipliers, stopped flow syringes, loading syringes, electronics unit, and PC. 
Drive syringes were installed into the device to give a desired refold ratio. Syringe sizes 
were 2.5 mL, 500 µL, 250 µL and 100 µL. This allowed for mixing ratios 1:25, 1:10, 
1:5 and 1:2.  The larger of these stopped flow syringes was loaded with the refolding 
buffer using a loading syringe, injected in from the top. The smaller was loaded with the 
protein sample in urea. 
The device was calibrated for the individual protein, its buffer, and the wavelength at 
which the anisotropy would be measured; 280 nm or 297 nm. 280 nm was used to 
measure the signal fluorescence especially as CytC contains a single tryptophan residue. 
This involved ensuring the voltage of the photomultipliers was sufficient enough to give 
an accurate reading for the protein sample, zeroing any offset signals produced when no 
chromophore is present, and accounting for the G factor; the difference in gain between 
the two detectors. 
112 
 
Data was collected through the PC using the Pro-Data software. This software was run 
in “Kinetics” mode, using the “Fluorescence Polarisation” option for taking 
measurements. The source of the drive syringe was also determined using this program; 
manually or internally using the gas pump, depending on application. When using an 
internal trigger, nitrogen gas at a pressure of 8 bar was used to power the exit syringe, 
whilst a pressure of 4 bar was used to drive the separate mixing syringes. 
Using the same stopped flow mixing setup, this equipment is also capable of measuring 
fluorescence and absorbance of the kinetics within the stopped flow cell. This is 
achieved by fitting an absorbance detector opposite the light source side of the cell, with 
a photomultiplier tube present at a right angle to the incoming light beam. Absorbance 
was measured using light emission at 320 nm. Fluorescence studies were carried out 
using the fluorescent probe ANS (40122-0050, Acros Organics, Fisher). ANS was 
present in solutions for fluorescence measurements in excess at 1×10
-5 
M. Fluorescent 
studies of the probe binding were carried out at 370 nm. 
In experiments where mixing ratios were altered, the initial protein concentration was 
also altered to scale in order that the final concentration of protein was maintained. This 
is especially important in the aggregation studies in order that intensities be comparable 
between runs. In order for the final concentration of 0.77 mg/mL (w/v) protein to be 
maintained, initial solutions of protein were prepared following  Table 4.7. 
 Table 4.7: Initial protein concentrations for each refold ratio. 
 
  
Refold Ratio Initial Protein Concentration (mg/mL) 
1 to 5 4.6 
1 to 10 8.46 
1 to 25 20 
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4.3 Small Angle Neutron Scattering 
The objective of this experiment was to use small angle neutron scattering to understand 
the formation and overall structure of spherical aggregates of bovine serum albumin 
(BSA). The following experiments were performed at the Instituit Laue-Langevin, 
Grenoble, France, on beamline D22; a small angle neutron scattering beamline.  
In order to characterise the aggregation process, two categories of experiments were 
run: static measurements (where pre-aggregated samples were placed in the beam for 
analysis) and dynamic measurements (using the temperature control feature on the 
sample rack to aggregate samples and analyse the aggregation process in real-time). 
Sample Creation 
Static samples were created prior to the experiment using a 2 mg/mL concentration of  
BSA ( sourced in Table 4.1) with 100mg of protein being measured into 50 mL of a 
buffer containing 100 mM Tris, 100 mM NaCl pH 7.4 (adjusted with HCl) buffer: 
Table 4.8:Component list of Tris buffer for static experiments 
200 mL H2O 
Tris  Stock 
Buffer 
Reagent Mass 
Tris(hydroxymethyl)aminomethane 2.4228g 
NaCl 1.1688g 
 
Samples were then incubated at set temperatures for specific times to allow the 
aggregation process to be completed: 
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Table 4.9:Temperatures and corresponding times for aggregation 
Temperature ( 
˚
C) Time (h:m) 
70 7:00 
72 3:30 
74 2:00 
76 1:30 
78 0:55 
After the designated duration, samples were then placed on ice, diluted by 75 % with 
D2O (375 µL aggregate sample combined with 1125 µL of D2O), and placed in 2 mm 
pathlength cells ready for insertion into the beamline. 
 
Figure 4.2:Scattering length density of buffer with varied H2O:D2O.[1]z 
D2O was added to the aggregate solution to ensure good contrast between the protein 
and the solution, whilst a high D2O concentration is also required to reduce incoherent 
scattering and ensure each sample could be scanned in an appropriate time. The 
scattering length density of BSA was calculated at 2.97×10
-6 
Å
-2
 which appears 
comparable with other calculations [2]. Using the data from Table 4.2 a D2O fraction of 
0.75 has a scattering length density of 4.62 ×10
-6 
Å
-2
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Dynamic samples were created using 2 mg/mL concentration of bovine serum albumin, 
starting with an initial stock solution of 20 mg/mL, created from 200 mg of BSA into 10 
mL solution of ultrapure H2O. This was then diluted into in a 100 mM Tris, 100 mM 
NaCl (sourced Table 4.4) , buffer made up in D2O,  pD7.4. This was diluted at a 1:9 
ratio, with 70 µl of protein sample to 630 µl of buffer to give a final concentration of 2 
mg/mL BSA in a 90 % D2O buffer solution with a scattering length density of 5.62 ×10
-
6  
Å
-2
. 
Table 4.10: Component list of Tris buffer for dynamic experiments 
50 mL D2O Tris Stock Buffer 
Reagent Mass 
Tris(hydroxymethyl)aminomethane 0.6050g 
NaCl 0.2922g 
 
This was put directly in quartz cells of 2 mm pathlength in preparation to be placed in 
the beam. 
Data Collection 
Data from static samples were collected at two separate camera lengths: 2 m (run for 10 
min per sample) and 11.2 m (run for 20 min per sample). The collimation for the 
samples was the same distance as the camera length.  
Dynamic samples were run at 3 camera lengths: 2 m, 4 m, and 11.2 m, with the 
collimation distance being identical to the camera length. Samples were run at 2 
temperatures; 75 ˚C and 80 ˚C. At each temperature and camera length, the data was 
divided into 1 min increments. At 80 ˚C, this was performed for 60 minutes, and at 75 
˚C for 120 minutes to allow adequate time for aggregation to occur. In addition to the 
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aforementioned temperatures, a final run of 70 ˚C was compiled with the detector 
distance set at 4 m. This was allowed to run overnight. 
Over 1100 spectra were collected in total. GRASP [3] was used for data handling, 
including calculation of the beam centre, background and transmission corrections and 
radial averaging. For the dynamic runs this was completed for each individual spectrum, 
rather than an average of the set in order to analyse minute by minute changes 
associated with the aggregation process. 
4.4 Rotor Gene Fluorescence 
The Qiagen Rotor-Gene Q is primarily a real time PCR machine capable of rapidly and 
accurately heating samples whilst monitoring the UV absorbance or fluorescence of the 
sample. This also enables the Rotor-Gene Q to be used to monitor the unfolding of a 
protein with the use of a fluorescent probe which binds to the unfolded protein and 
fluoresces. Here the hydrophobic probe used was 1-anilinonaphthalene-8-sulfonic acid. 
This technique was used to specifically examine the thermal stability of bovine serum 
albumin in a 90 % D2O solution. In order to achieve rapid and accurate heating, small 
volumes are required; therefore a PCR tube containing 100 μL of solution was used. In 
order to mimic the conditions of the dynamic SANS experiments, identical reagents 
were used to create a 90 % D2O solution. This was created using 90 μL D2O (Sigma), 5 
μL of 300 μg/mL ANS (Fisher) and 200 μg of BSA (Sigma) to create a 2 mg/mL final 
protein concentration. This procedure was run in triplicate with a 90 % D2O 15 μg/mL 
ANS containing no BSA used as the reference. The melt was carried out at 6 ºC/min 
between 35 ºC and 95 ºC, where the fluorescence was measured under the “Blue” 
channel which provides Excitation at 365 nm and detection at 460 nm, allowing the 
change in fluorescence of the probe to be detected. 
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4.5 Environment Scanning Electron Microscopy (ESEM) 
Protein aggregate samples were measured using a Quanta 250 SEM in ESEM mode, 
using a Peltier stage for sample control and gaseous secondary electron detector 
(GSED) for detection. Aggregate samples produced using the UVLSS procedures were 
extracted from the cuvette after cooling to room temperature. Aggregate samples were 
placed into 2 mL eppendorf tubes and centrifuged  at 14000 rpm for 60 s in an 
Eppendorf Minispin Plus  centrifuge. Superfluous liquid was drained from the sample, 
and replaced with ultrapure water, and the aggregates were resuspended, before 
centrifuging again at 14000 rpm for 60 s. This process was performed three times to 
remove any salt from the sample, and prevent formation of salt crystals during 
microscopy. The aggregate sample was then transferred to an aluminium stub for  
loading onto the Peltier stage. The sample was allowed to equilibriate for 30 minutes at 
5 ºC, before the pressure was reduced to 2.84 Torr and imaging performed at 15 kV. 
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Chapter 5 : Aggregate Nucleation 
5.1 Introduction 
This chapter details the treatment and analysis of data from small angle neutron 
scattering experiments carried out at D22 at the Insituit Laue-Langevin, Grenoble. The 
aim of these experiments was to characterise the formation and growth of particulate 
aggregates of bovine serum albumin on a nanometre scale, and elucidate nucleation 
kinetics from these findings. 
5.2 Experimental Overview 
Bovine serum albumin at a concentration of 2 mg/mL was subjected to a temperature 
increase and then held at that temperature for a period of time. This was performed at 
three temperatures; 70 ºC, 75 ºC and 80 ºC, and repeated with scattering data collected 
at three detector distances; 2 m, 4 m and 11.2 m, (except the 70 ºC experiment in which 
3 samples were simultaneously measured at 4 m), in order for the scattering intesity 
changes over the full q range to be analysed. 
 5.3 Data Treatment 
Raw data from these experiments was collected in the form of a two dimensional 
scattering pattern (Figure 5.1). Initially a mask was applied over the area of the beam 
stop to negate any bad data pixels registering intensity values on an area of detector 
which is behind the beam stop. A number of corrections were applied to the data to 
extract the two dimensional scattering produced by the protein alone. Factors that 
needed accounting for were: sample container scattering, buffer scattering, the 
transmissions of these elements (including the sample itself), and residual scattering 
produced from the surrounding environment. 
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Figure 5.1: Raw data scattering pattern obtained from BSA at 75 ºC at 4 m. A mask has been applied over the 
beamstop. 
In order to correct for the scattering from external sources (those other than the protein 
sample) scattering from the sample container containing solely buffer was collected, and 
for the environmental scattering, cadmium was placed in the beam in order to absorb the 
full forward transmission. These data sets were collected for each temperature run and 
at each detector distance and collection time was identical to the collection time of the 
corresponding data set.  
In order to background subtract the data sets, transmission values for both the sample 
(Ts) and background sample (Te) were also obtained [1].  Where Ts (Equation 5.1), and 
Te (Equation 5.2) can be calculated from counts of the neutron beam before and after the 
sample. 
   
                                                   
                                           
 
Equation 5.1: Equation for calculation of sample transmission. 
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Equation 5.2: Equation for calculation of empty cell transmission. 
The values of these transmissions and the background scattering intensities can then be 
used to obtain the corrected value for the scattering from the sample (Equation 5.3). 
           
 
    
(      )  
 
  
(       ) 
Equation 5.3: Calculation of corrected intensity from transmission and background scattering values. 
Where Icorrected is the corrected scattering from the sample, and Is, Icd and IBk the initial 
scattering from the sample, cadmium, and empty cell respectively. This process, applied 
through use of the programme GRASP [1], enabled the scattering pattern of the sample 
to be obtained (Figure 5.2). It can be seen that when compared with the raw data 
sample, the corrected data contains a flat background at the higher angles; illustrated by 
the blue on the scale, whilst the scattering from the sample is still prominent at the 
lower angles. 
 
Figure 5.2: Corrected scattering pattern for BSA at 75 ºC at 4 m. 
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In order to define the q range of the scattering pattern, first the beam centre was 
determined so that the central pixel could be used as to calculate the distance from the 
centre to each individual pixel. GRASP will determine the central pixel from the 
intensity of the beam profile (Figure 5.3). This central pixel value is also used as the 
base point from which the radial averaging of the scattering pattern is performed. 
 
Figure 5.3: Attenuated beam profile on 4 m detector. Note: this is a magnified view when compared to previous 
scattering figures. 
As the protein samples were isotropic, each scattering pattern could be radially 
averaged, and intensity versus scattering vector could be obtained. Radial averaging 
takes the intensity of each set of pixels at the same distance from the centre, and 
averages the pixels at every distance. The resultant plot is shown in Figure 5.4. The 
radial averaging does not include any pixels whose average would be calculated from 
pixels behind the beam stop or mask, as there are not sufficient pixels to give reliable 
statistics on the intensities so close to the beam stop (Figure 5.5). The resultant data was 
then exported as a .csv file where it could be manipulated in the data handling program; 
Mircosoft Excel.  
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Figure 5.4: Intensity versus scattering vector plot of BSA at 75 ºC at 4 m. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Beamstop 
Detector area omitted from averaging 
Detector area where radial averaging takes place. 
Figure 5.5: Diagram to illustrate omitted detector area from radial averaging process. 
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The data in its current form, although individually corrected, was not normalised across 
the 3 detector distances, therefore the intensities were not comparable (Figure 5.6). 
 
Figure 5.6: Corrected scattering data for the first minute of BSA at 75 ºC at 3 detector distances. 
In order to make the three data sets combine into one comparable set of data, both the 4 
m and 11.2 m data were normalised using a scaling factor so that the intensities of the 
data at each scattering vector were of similar values. In order to perform this, the data 
was normalised to the 2 m data, as that had a sufficient flat background from which to 
start from (Figure 5.7). This normalisation was performed for both the 80 ºC and 75 ºC 
data sets, with each normalisation being performed across the entire time course of data. 
Points at which the intensities from different detectors overlap showed good agreement 
with where the errors on the data points began to increase (the error bars in Figure 5.6 
and Figure 5.7 have been omitted for clarity). Additionally, as the intensity of the 4 m 
and 11.2 m data were scaled, the same scaling was applied to the magnitude of the 
errors in order to maintain the proportions between data magnitude and error bar size. 
The data normalisation maintained its integrity throughout the time course of each 
experiment (Figure 5.8)  
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This completed the handling of the raw data, which was now in a format suitable for 
analysis. 
Figure 5.7:Normalised scattering data for the first minute of BSA at 75 ºC at the 3 detector distances. 
 
 
Figure 5.8: Normalised data of BSA at 75 ºC, after 228 minutes 
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5.4 Data Analysis – Native Protein 
An initial scattering plot of bovine serum albumin (Figure 5.9) before heating was 
produced from the data collected across the 3 detectors ranges complete with errors. The 
magnitude of error bars increases at the inner and outer limits of each data set, owing to 
the lower number of pixels contributing to the intensity value at the specific q value. 
Where the error bars are large the overlapping data set contains more reliable data, 
therefore the majority of the range retains good statistics. 
 
Figure 5.9: Log intensity against scattering vector  plot for native BSA. 
When both axes are placed on a logarithmic scale, the surface parameter of the native 
protein can be elucidated (Figure 5.10). This figure shows that as the gradient is seen as 
q
-4
 the protein can be seen as spherical, which is to be expected from a folded protein in 
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its native state such as bovine serum albumin is here. Some of the more erroneous data 
points have been omitted for clarity. 
 
Figure 5.10: Log-log plot of native BSA. 
The size of the particles was also estimated. The monomer was homogenous and in a 
dilute solution therefore the Guinier equation could be used to obtain a radius of 
gyration for the particle.  
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Equation 5.4: Guinier equation. 
Equation 5.4 states the Guinier equation where r is given as the radius of gyration. This 
was applied to the scattering pattern of the BSA in solution (Figure 5.11). Equation 5.4 
was applied to the data only over the applicable Guinier region, where q×Rg > 1.3 [2]. 
The extracted radius of gyration value was 33.9 ±0.9 Å. This appears in agreement with 
other values obtained for the radius of gyration of BSA [3-5], where the value is 
/c
m
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generally considered to be around 30 Å. The value obtained here appears to be 
marginally larger, which may be attributed to the destabilising effect that D2O may exert 
on the protein. This reported value can be stated with confidence however, as all native 
BSA samples reported near similar radius of gyration values. 
Figure 5.11: Guinier fit of native BSA. 
As the native structure of BSA is solved [6] (PDB code 3V03) it is possible to fit the 
theoretical solution scattering of the structure to the obtained scattering pattern. This can 
be performed using the programme CRYSON [7]. This programme takes the data input 
in the form of the PDS file and creates a spherically averaged scattering pattern which 
takes into account the hydration shell and extent of deuteration present in the sample. 
CRYSON attempts to minimise the difference in the chi-squared value between the 
predicted and experimental data to give values for the hydration levels and envelope 
size of the protein. This was performed for BSA, however: the PDB structure of BSA is 
in the dimeric form, and as the studied solution of BSA should be monomeric a PDB 
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file was created involving solely the monomer chain (this function is not available in 
CRYSON, but in the near identical father programme CRYSOL [8], available in the 
same ATSAS package). 
 
Figure 5.12: CRYSON fit of BSA crystal structure to obtained scattering data. Error points are identical to Figure 5.9, 
and omitted to show the quality of the fit. 
The fit of the BSA theoretical structure (red line) shows an excellent fit to the obtained 
scattering data in Figure 5.12. This agreement was reached assuming an 80 % 
deuteration of available surface exchange atoms, and produced values for the volume of 
BSA at 82666 Å
3
 and a radius of gyration of the envelope of 32 Å.  The deuteration 
appears in agreement with the proposed levels of deuteration from BSA molecules [9, 
10] whilst the radius of gyration is in good agreement with results from the Guinier plot 
(Figure 5.11). 
To assess the quality of the native protein fold, a Kratky plot was produced of the native 
BSA sample (Figure 5.13). The bell shape with a decrease to the baseline of this plot is 
a prime example of a Kratky plot of a globular folded protein sample [11].  
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Figure 5.13: Kratky plot of native BSA. Error points are identical to Figure 5.9, and omitted to show the quality of the 
fit. 
These initial data treatments show that the 2 mg/mL bovine serum albumin in a 90 % 
D2O solution is in a monomeric form with a radius comparable to that seen in other 
experiments. It is in a natively folded, globular state, with 80 % of deuterated surface 
hydrogens. All results shown here are comparable with the literature. Thus the 
experiments carried out here can be considered to probe the behaviour of the native 
BSA protein molecule under heating. 
5.5 Data Analysis – Heat Increase 
Similar methods can be applied to the protein during the heating phase of the 
experiment to probe any structural changes that occur during the heating of the protein 
solution.  
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Figure 5.14: Intensity versus scattering vector plots of BSA at 25 ºC (closed diamonds) and after just reaching 80 ºC 
(open diamonds) taking 7 minutes. Error points are omitted to allow comparison. 
During the heating phase of the experiment, it can be seen that there is very little 
difference in the intensity plot of the native BSA sample when compared to that of the 
sample which has been heated (Figure 5.14). In this example the frame is taken as the 
one preceding aggregation detection. In this case there are only seven frames leading up 
to the aggregation, however the same can be seen to be true of both the experiments at 
70 ºC and 75 ºC where 25 frames are present, representative of 25 minutes (Figure 
5.15). Both 75 ºC and 70 ºC exhibit similar initiation times, however only the 75 ºC data 
is shown here as it is presented over a larger q range than the 70 ºC data. As can be seen 
in both figures, there is little change in the intensities at low q, therefore there are now 
larger structures appearing (i.e. aggregates) and there appears to be minimal difference 
in the scattering present at high q. 
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Figure 5.15: Intensity versus scattering vector plots of BSA at 25 ºC (closed diamonds) and after just reaching 75 ºC 
(open diamonds) after 25 minutes. Error points are omitted to allow comparison. 
The y axis of a Kratky plot factors the intensity by q
2
, which results in any small 
changes in the high q intensity to be amplified. This gives a good indication of any 
differences in the plots during the heating stage, and will also assess the quality of the 
protein fold during heating. The ramp up to 75 ºC heating is used as a prime example 
(Figure 5.17). In the initial stage at 25 ºC, the Kratky plot peaks and drops down to the 
baseline as was seen in the Kratky plot of the native protein (Figure 5.13). As the 
temperature rises to 45 ºC, there is still very little deviation from the baseline at the 
higher q values. At a temperature of 65 ºC, there is a significant increase in the baseline 
of the Kratky plot at high q. This is indicative of the protein being in the partially folded 
state and a loss of globular shape. This transition in the protein structure in the range 
leading up to 65 ºC appears to correspond to a melting temperature seen in a differential 
scanning calorimetry study of BSA [12] in which the melt range was seen to be between 
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56 ºC and 69 ºC. At this temperature the loss of intra protein interactions must be 
sufficient enough to change the overall form of the protein to a slight random coil-like 
structure [13]. 
The conditions for these experiments require the protein to be present in a 90 % D2O 
solution. In order to understand the effect this may have upon the unfolding 
characteristics of the BSA molecule, a fluorescence study was undertaken. The 
fluorescence probe 1-anilinonaphthalene-8-sulfonic acid was used to probe hydrophobic 
exposure on the protein during a heat ramp. This was performed for increasing 
concentrations of D2O in the buffer solution. 
 
Figure 5.16: Change in fluorescence over time of ANS with BSA in 90 % D2O solution. 
It was found that increasing concentrations of D2O in the sample buffer led to a slight 
decrease in the melting temperature of BSA. The melt temperature for BSA in 0 % D2O 
was calculated at 83.8 ºC whilst for BSA in 90 % D2O it is 78.4 ºC. These values also 
correlate with the figures given from calorimetry results [12]. Figure 5.16 illustrates the 
unfolding characteristics of BSA at 90 % D2O concentration, comparable to that of the 
SANS experiments detailed here. 
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Figure 5.17: Kratky plot of BSA heated up to 75 ºC, at 25 ºC (closed diamonds), 45 ºC (open diamonds), 65 
ºC(closed squares), 75 ºC (open squares). Error bats are omitted to show difference in the plots. 
The deviation from the baseline at high Q is seen to increase further as the protein in 
solution reaches 75 ºC. This indicates further unfolding of the protein structure. At this 
stage, the protein is still largely globular, as is evident in the remaining peak presence in 
the Kratky plot at 75 ºC. This however, is the total extent of the protein unfolding seen 
in the Kratky plot before aggregation takes place. Continued exposure of the protein to 
this temperature does not lead to any further unfolding to the BSA molecule, which 
would be illustrated in the Kratky plot as a continuing increase in the q
2
I intensity to 
high q resulting in no peak in the plot. This correlates well with the literature which 
indicates that complete unfolding of BSA may not occur until almost 90 ºC [14].  This 
data shows that only partial unfolding of the BSA molecule is required in order for 
aggregation to occur. This partial loss of tertiary structure is sufficient for the 
hydrophobic areas of protein which contribute to this loss of structure to cause binding 
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between protein monomers and initiate aggregation. This particulate aggregation 
behaviour appears concurrent with other amorphous aggregation of BSA within the 
literature, in terms of only perturbed tertiary structure being necessary for aggregate 
formation [15]. 
 
Figure 5.18: Guinier plot of BSA after 7 minutes of heating to 80 ºC 
Figure 5.18 illustrates the Guinier plot of the BSA before aggregation during heating to 
80 ºC. The plot shows that the radius of gyration of the monomer has increased slightly 
at 35.13 ±1.86 Å, so this increase can be taken with minimal certainty as it appears 
within the range of error in the monomer. Similar values are also seen in the additional 
experiments where the pre aggregation frames showed radius of gyration values of 
36.40 ±1.9 Å and 36.20 ±0.74 Å for the monomer at in the 75 ºC and 70 ºC runs 
respectively (Figure 5.19 and Figure 5.20).  
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Figure 5.19: Guinier plot of BSA after heating to 75 ºC for 25 minutes. 
 
Figure 5.20: Guinier plot of BSA after heating to 70 ºC for 24 minutes. Error bars are the size of the points. 
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These values for the radius of gyration in combination with the Kratky plots illustrate 
the partially folded swollen nature of the BSA intermediates which are present before 
aggregation occurs. These can be considered to be the aggregate prone intermediates 
which form the initial aggregate nuclei. 
5.6 Data Analysis – Aggregation 
After the increase in heat of the protein sample, protein aggregation can be seen to 
occur, characterised by an increase in intensity at low Q (Figure 5.21). This is indicative 
of larger structures becoming present in the illuminated sample volume, in this case; 
protein aggregates. 
 
Figure 5.21: Intensity plot of BSA at 80 ºC before (open diamonds), and 10 minutes into the aggregation process 
(closed diamonds) 
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The protein sample is held at an isothermal temperature for the remaining duration of 
the experiment. As this continues, the intensity at high Q is seen to increase with time 
(Figure 5.22). This is caused by the continual increase in size of the large structures 
within the sample. 
 
Figure 5.22: Progression of scattering intensity from BSA whilst heated at 80 ºC for  1 min(closed squares), 10 
min(open squares), 20 min (closed circles),30 min (open circles) 40 min (closed triagnles), 50 min (open triangles) 
From the log intensity plot of the initial BSA monomer (Figure 5.10), we can see how 
the monomer can be considered as a sphere, although this is an approximation of its 
perturbed globular form. As aggregation progresses, the structures within the sample 
maintain a spherical form (Figure 5.23), which is to be expected, as it is shown that 
aggregates formed at around this pH will form spherical aggregates [16, 17]. As the 
temperature is maintained, the structures formed no longer adhere to a q
-4
 decay, instead 
dropping off at a rate of ~q
-2.2
 indicative of a Gaussian chain. This can be caused by the 
clustering of particulate aggregates together in order to form these large chains [13]. 
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This is a feature only observed in the experiments performed at 80 ºC, in both the 75 ºC 
and 70 ºC experiments, the profile of the log intensity graphs remain similar to that of 
the native state (Figure 5.10). This suggests that during these runs the protein aggregates 
maintain their spherical form throughout the experiment and do not cluster into chains. 
Reasons why this may be the case will be considered further on in this chapter. 
 
Figure 5.23: Log Log plot of BSA 1 min, 10 mins and 30 mins into aggregation at 80 ºC, ordered through the depth 
of the graph. 
As previously noted, the BSA molecules can be considered to be spherical (Figure 
5.10). The scattering from dilute spheres of known scattering length density contrast, 
scattering volume and radius can be modelled using the Rayleigh equation [18]. For a 
homogenous sphere with a radius R, the form factor of the spheres, P(q) is: 
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Equation 5.5: Rayleigh scattering from homogenous spheres. 
As this is a dilute system, S(q)=1, therefore the equation above describes the scattering 
from the BSA molecules completely, when considered as spheres. 
When Equation 5.5 is fitted to the monomer, a good fit is achieved (Figure 5.24).  The 
Rayleigh slope fits well at low q, where the majority of the high quality data lies. At 
higher q, the low resolution data deviates from the Rayleigh plot, which will be due to 
the low count time taken over this range, and some smearing effects. The radius 
reported from the Rayleigh plot of 36.5 Å does appear small in comparison to the radii 
of gyration achieved from Guinier plots of the same data, it does bear some agreement 
to other values for the radius of hydration presented in other papers on BSA [19], where 
the value was given as 33.9 ±2.7 Å.  
 
Figure 5.24: Fit of Rayleigh scattering from a homogenous sphere to scattering intensities from BSA monomer. 
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It has been shown from the scattering plots that both the monomer and the aggregates 
can be considered as spheres. By creating a model based on the Rayleigh scattering 
from spheres in Equation 5.5, values can be obtained for the radius of the aggregate at 
each time point, along with the relative ratio between scattering from spherical 
monomer, and scattering from spherical aggregates. For form factor amplitudes from 
monomers Fm(q) of radius Rm and aggregates Fa(q) of radius Ra: 
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Equation 5.6: Amplitude for Rayleigh scattering from monomer. 
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Equation 5.7: Amplitude for Rayleigh scattering from aggregate. 
 
Where: 
 ( )     
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Equation 5.8: Scattering equation for dual population of monomer and aggregate spheres. 
Where: 
        
Equation 5.9: Calculation of volume fraction of aggregate. 
Where Vm is the volume fraction of the monomer, hence Va will return the volume 
fraction of the aggregate. I0 is a scaling factor, v the volume of the scattering bodies, and 
Δρ is the difference in scattering length densities before the protein and the solution. 
142 
 
As in Equation 5.5, there is considered to be no particle interactions as the number of 
particles is the same or decreasing as aggregation occurs. If this is found not to be true, 
then the difference between the modelled and collected data should yield a curve with 
resemblance to that of a structure factor, with S(q) tending towards 0 at low q. With the 
initial volume fraction and monomer radius known, it is possible to model the ratio 
between the Va and  values by subjecting them to the known limit (that of the initial 
monomer volume fraction) whilst allowing the aggregate radius to be free to fit to the 
scattering curve provided the aggregate radius was larger than that of the monomer. 
This was applied to each scattering plot run at the three experimental temperatures, with 
the resultant data being a product of fitting this model to over 300 scattering plots. 
 
Figure 5.25: Dual population sphere fit to 20 minute frame of BSA at 75 ºC. 
Figure 5.25 is an example of the model fit fit to the data, created using Equation 5.8. 
The model once again shows an excellent fit at the majority of the data, which is present 
at the low q scale and also with the high q data. There is also small evidence of the data 
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showing some fit to the minima within the model fit to the plot, albeit with the presence 
of data points with very high error in these regions. 
Complete fitting of the data set for each temperature run yields the values of both 
aggregate radius and monomer fraction over a time course. 
 
Figure 5.26: Aggregate radius growth of BSA over time when incubated at 80 ºC. 
Data is normalised so that the first time frame represents the first detection of aggregate. 
As the initial aggregate size detected is of the order of 90 Å, whilst the monomer only 
has a radius of ~30 Å, it is possible that aggregates may exist at a smaller size range 
than this, but they are either a) indistinguishable from the monomer in terms of the 
model or b) not stable enough to maintain the size population. 
Figure 5.26 illustrates the rapid growth in aggregate radius that occurs initially, 
followed by a much slower growth rate when the protein is around 600 Å in radius. This 
effect is mirrored in Figure 5.27 where the monomer is depleted rapidly until 1000s into 
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aggregation. From this stage the depletion of monomer is slowed and lies in good 
correspondence with the slow in growth rate of radius in Figure 5.26. 
 
 
Figure 5.27: Monomer fraction depletion over time of BSA at 80 ºC. 
A noticeable discrepancy is visible in Figure 5.27 over the initial time frames where 
there is some variation in monomer fraction that does not tend towards 0 as time 
decreases. This may be the result of a low amount of scattering coming from the 
aggregates at this stage due to their low size and concentration. As a result the model 
may have difficulties separating this scattering from the monomer, leading to a higher 
error in the points at the start of the experiment. When compared together (Figure 5.28) 
at these initial values will also show how some dependence exists between these two 
parameters within the model; however this only seems to exist in instances of low 
aggregate scattering. 
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Figure 5.28: Monomer fraction (closed squares) and aggregate size (open squares) progression over time for BSA 
incubated at 80 ºC. 
 
Figure 5.29: Monomer fraction (closed squares) and aggregate size (open squares) progression over time for BSA 
incubated at 75 ºC. 
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Figure 5.29 and Figure 5.30 illustrate similar characteristics of the aggregation of BSA 
at lower temperatures (75 ºC and 70 ºC respectively). Similar trends are present in these 
plots to those of 80 ºC; the emergence of monomer fraction appears at circa 0.85, whilst 
aggregate size emerges at 100 Å. There is an instance of aggregates emerging at 45 Å in 
Figure 5.29, however the errors related to this data are significantly large. This will be 
due to both the rapid growth change that may be occurring over the minute acquisition 
time for these data points and the low percentage of scatter produced from this small 
concentration of aggregates. 
 
Figure 5.30: Monomer fraction (closed squares) and aggregate size (open squares) progression over time for BSA 
incubated at 70 ºC. 
 
The rates at which aggregation occurs is temperature dependent as evident in the 3 plots 
(Figure 5.28, Figure 5.29, Figure 5.30). A high temperature results in a quicker 
depletion of the monomer fraction (to 0.1 over the course of 1000 seconds: Figure 5.28), 
over a lower temperature (at 70 ºC the monomer fraction is reduced to 0.6 after 25000 
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seconds: Figure 5.30). All plots do show a consistent decline and tend towards zero, 
indicating that aggregation will continue until the entire monomer population is 
depleted. 
The aggregate radii are seen to form more quickly and result in larger sizes (800 Å at 80 
ºC over 100 Å at 70 ºC). This correlates with the monomer depletion plots, where slow 
linear monomer depletion in the latter stages is mirrored by slow rate linear growth. 
This may indicate that the aggregate population is stable, as the changes in rates appear 
proportional. 
Aggregate concentration Ca, assuming all aggregates are of identical spherical size can 
be calculated by Equation 5.10, from the monomer fraction Mf and number of 
monomers in each aggregate AN, where C0 is the initial monomer concentration of the 
BSA at 3.01×10
-5 
M. 
   
       
  
 
Equation 5.10: Calculation of aggregate concentration. 
The number of monomers in an aggregate is a ratio between the volume of the 
aggregate and the volume of a BSA molecule, where its radius; Rm is taken as 34.37 Å 
and aggregate radius Ra is derived from the data. 
   
  
 
  
  
Equation 5.11: Calculation of number of monomers in an aggregate. 
 
148 
 
 
Figure 5.31: Number of monomers in aggregates (closed squares) and aggregate concentration (open squares) for 
BSA at 80 ºC. Errors are of magnitude replicated in Fig 5.29. 
 
Figure 5.32: Number of monomers in aggregates (closed squares) and aggregate concentration (open squares) for 
BSA at 75 ºC. Errors are of magnitude replicated in Fig 5.30. 
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Figure 5.31 illustrates the aggregation behaviour of BSA at high temperature. Initially 
the aggregate concentration starts high (~1.4×10
-7 
M).  This is the first detectable 
aggregate concentration, therefore these aggregates are considered to have formed at 
sizes and concentrations which the model is unable to separate from the scattering 
produced from the monomers. The closed squares in Figure 5.31 indicate that the initial 
aggregates consist of 30 monomers before rapid growth in size, with an “S” shaped 
growth where the slower phase of aggregate growth is occurring at around 8000 
monomers in size and the aggregate concentration remaining stable at ~ 2.9×10
-9 
M. 
Figure 5.32 illustrates a similar trend to that seen in at 80 ºC, with the aggregate 
concentration decreasing whilst the size of aggregates increases. Both plots are less 
extreme than those seen at 80 ºC, where the resultant aggregates contain fewer 
monomers. 
 
Figure 5.33: Number of monomers in aggregates (closed squares) and aggregate concentration (open squares) for 
BSA at 70 ºC. Errors are of magnitude replicated in Fig 5.31. 
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Figure 5.33 illustrates the aggregation behaviour of BSA at 70 ºC. Here it can be seen 
that the number of monomers in an aggregate are present at a consistent size, 
representative of around 42 monomers in each aggregate. The concentration of 
aggregates shows an initial decrease (which may be within experimental error) before a 
rapid growth with an exponentially decreasing rate. The concentration of the aggregates 
maintains a steady increase through the latter stages of the experiment which it appears 
would continue past the final timeframe of the experiment. 
At the high temperatures, the decrease in aggregate concentration indicates that small 
aggregates may be combining together to form larger aggregates, which certainly 
appears possible as the monomer content in each aggregate at minimum doubles over 
each time frame. This appears a more robust argument for the aggregate concentration 
decrease over the unstable aggregates reverting to monomeric form, as at a monomer 
count of 30, the aggregate would be expected to be stable as it is much larger than other 
examples of stable aggregate [20, 21]. A similar mechanism can be applied to the 
aggregation behaviour at 75 ºC, as Figure 5.32 exhibits the same attributes as Figure 
5.31.  
This aggregation behaviour can be described in terms of the unfolding of the BSA 
molecule. Thermal unfolding of BSA begins at around 60 ºC and continues until 90 ºC 
[12], however the shift seen with the behaviour in 90 % D2O is shifted down by ~5 ºC 
(Figure 5.16). At 80 ºC the BSA monomer is structurally perturbed and a large fraction 
of the molecule has exposed hydrophobic regions which are highly “reactive” (capable 
of self association and). In order for protein molecules to associate, hydrophobic regions 
on the each colliding protein must interact. The results indicate that these “reactive” 
monomers interact with each other in a manner which maintains or increases the overall 
“reactive” surface area percentage of the small aggregate. As the concentration of free 
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monomer is solution is still large (Figure 5.28), it is the increased reactivity of the small 
aggregates which drives their self association until they decrease in concentration. 
These small aggregates have a much higher “reactivity” than the perturbed monomer, 
therefore collisions between small aggregates is the driving force in aggregate growth, 
characterised by the large aggregate growth change whilst there is little monomer 
depletion. Although this appears novel for particulate aggregates, the association of 
oligomers during a protein nucleation “burst phase” has been modelled in the formation 
of fibrils [22, 23].  
The resultant aggregates formed from the clustering of small aggregates are less 
“reactive” than the small aggregates. A separate explanation would be that the 
aggregates are at such a low concentration in relation to the concentration of monomer 
that they fail to interact. However, at an aggregate concentration of 6×10
-8 
M, there is a 
markedly different rate of aggregate growth at 80 ºC and 75 ºC (Figure 5.31, Figure 
5.32). At 80 ºC at a concentration of 6×10
-8 
M aggregates, proposed small aggregate 
clustering is occurring, whilst at 75 ºC, it is the proposed monomer addition. This 
indicates that the reactivity of the respective aggregates must differ. The emergence of 
the larger, less “reactive” aggregates results in monomer addition becomes the 
prevailing growth mechanism, which would be more thermodynamically favourable 
than new aggregate nuclei forming [24], where aggregate concentration is seen to be 
stable, and aggregate growth slow, due to the small impact on radius each subsequent 
monomer provides to the aggregate (Figure 5.31), and the low reactivity of the two 
particles (when compared to the small aggregates). A similar method is true for the 
experiment at 75 ºC, where the extent of monomer unfolding is less than that at 80 ºC, 
but still sufficient enough to increase the “reactivity” of the small aggregates, leading to 
aggregate self association as before. 
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At 70 ºC however (Figure 5.33) the extent of protein monomer unfolding is low. As a 
result, structurally perturbed monomers will still associate, however the “reactive” 
hydrophobic surface are of the aggregate may not increase. Therefore as the aggregate 
gets larger, the percentage of “reactive” surface area decreases. With growth this would 
decrease to such an extent that the aggregate becomes essentially non-reactive, as the 
chance of a “reactive” monomer colliding with the “reactive” surface area on the 
aggregate becomes miniscule. Therefore self association of “reactive” monomers is the 
sole method of aggregation when aggregates reach sufficient size, which results in both 
the size of aggregates remaining constant throughout the experiment, and the aggregate 
fraction increasing, with the rate relative to the monomer concentration. Both of these 
features can be seen in the plot in Figure 5.33.  
5.7 Data Analysis – Final Aggregate Structure 
Samples pre-aggregate at temperatures between 70 ºC to 78 ºC in 2 ºC increments were 
studied using SANS in order to determine the final overall structure of the aggregates. 
Additionally any trend between incubation temperature and structural features was 
investigated. 
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Figure 5.34: A log scattering plot of BSA aggregates formed at 78 ºC. Error bars are the size of the points. 
Figure 5.34 illustrates the analysis of the scattering plots in order to obtain a fractal 
parameter for the aggregates. The slope of – 2.3 indicates a mass fractal with irregular 
structure, possibly resembling that of a Gaussian chain, which would ideally give a 
value of -2. This represents the joined spherical aggregates clustered together in the 
form of the strand or aggregate network. Similar findings have been seen with the use of 
SEM [16].  
Figure 5.35 indicates the fractal parameters of the scans run on the 10 separate 
aggregate samples. It can be seen that there is little variation, or trend with temperature, 
in addition the repeat samples show good reliability in the samples. It can be assumed 
that there is no significant change in structure to the overall clustered aggregate, despite 
the effect temperature has on the size of the spherical aggregates [16] 
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Figure 5.35: Fractal parameters for BSA aggregated at varied temperatures. Each temperature value contains a repeat. 
 
5.8 Conclusion 
As this work complements work undertaken in following sections, the conclusions from 
this work are present within the conclusion section (Chapter 8), to prevent repetitive 
statements and allow cross-chapter discussion. 
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Chapter 6 : Aggregation Kinetics 
6.1 Introduction 
This chapter details experiments performed using ultra violet light scattering 
spectroscopy to elucidate the particulate aggregation kinetics on three protein structures; 
bovine serum albumin, lactoglobulin, and myoglobin. The change in aggregation rate 
across a temperature range is measured to extract the kinetics of each system, and the 
effect changes to the protein solution have on the aggregate growth kinetics is also 
studied. 
6.2 Experimental Overview 
 
Figure 6.1: Temperature profile recorded for a heat ramp up to an isothermal temperature of 67.5 ºC 
Protein in buffer solution at a concentration of 2 mg/mL was placed into a temperature 
controlled UV spectrophotometer, initially at 25 ºC. The sample was then heated up and 
held at the desired temperature (Figure 6.1). During both the heating rate and the 
isothermal hold, absorbance spectra were taken of the protein sample across a range of 
wavelengths. At the exact time a spectrum is taken a temperature probe registered the 
temperature within the protein sample to provide a data set which contains a spectra and 
temperature value for each time point in the aggregation process. This data collection is 
continued until the aggregation is complete, at which point the data logging process is 
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stopped. Further details on this procedure can be found within the methods and 
materials section. 
6.3 Data Analysis 
This section details the analysis process undertaken on each aggregation experiment to 
produce the data discussed further in this chapter.  One experiment is used as an 
example throughout to show the process and comparable features of each plot. 
In order to ascertain a suitable temperature range over which to perform the aggregation 
experiments, an initial experiment on a protein in solution was performed whereby the 
temperature was increased at a constant rate of 0.02 ºC/min from 25 ºC to 95 ºC. The 
absorbance of the protein was measured at a single wavelength; 320 nm. This 
experiment would yield information on at which temperature aggregation begins to be 
detectable using this experimental setup. An example is shown for myoglobin (Figure 
6.2).  
 
Figure 6.2: Temperature profile of β -lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8. heated at 
0.02 ºC/min 
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At 63 ºC there is a detectable change in the absorbance. Beyond this value aggregation 
is prevalent, indicated by the continued increase in absorbance. This appears to agree 
well with ranges stated in other publications, however some attention must be paid to 
the role the solution effects have on the aggregation temperature [1, 2]. The value 
obtained here was then used as a starting reference for studies using this sample.  
 
Figure 6.3: Absorbance spectra of lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8 heated to 68.1 
ºC. Time duration is depicted by increasing absorbance. 
 
Figure 6.3 illustrates spectra recorded for lactoglobulin whilst heating to 68.1 ºC. As the  
the protein is exposed to the high temperature over time, the absorbance increases. It 
can be seen that at the lower wavelengths (early aggregation), the increase in 
absorbance is larger than at the higher wavelengths (late aggregation). This wavelength 
dependent scattering will be used to extract information on the particle sizes within the 
protein sample. It can be seen initially that there is very little change in absorbance as 
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the protein solution is heated up until aggregation begins; characterised by the increase 
in absorbance across the spectrum. This increase is due to an increase in scattering; 
either due to more particles scattering the light, larger particles scattering the light, or a 
combination of the two. Towards the top of the scale the change in absorbance spectra 
abates; this indicates no change in scattering is occurring so the particles are no longer 
growing in size or number. Finally the drop in absorbance is representative of the 
aggregates coming out of solution and settling towards the bottom of the cell outside of 
the beam area, indicating an apparent drop in aggregate concentration. This stage is 
known as clustering of which there is no known model, therefore data collection stops 
once the absorbance peak is reached.  This therefore indicates an end to the aggregation 
process. 
 
Figure 6.4:Aborbance at 320 nm over time of lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8. 
Temperature is indicated by the line. 
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Figure 6.4 illustrates the same experiment as Figure 6.3, shown from the absorbance at 
320 nm with time values associated with them. The initial flat period at the start of the 
graph relates to the heating up of the protein in solution at a constant heating rate from 
25 ºC.  The start of the absorbance increase corresponds well with the temperature 
reaching its maximum value. Whilst the temperature is held isothermally, aggregation 
proceeds, as indicated by the increasing absorbance, until it reaches its maximum. At 
this point the aggregation process is complete. After the maximum absorbance peak, the 
decrease in absorbance can be interpreted as the aggregates decreasing in size or 
number, or this could also  be caused by the particles clustering, causing localised 
concentration fluctuations, which would be seen as a decrease in absorbance [3]. 
In order to analyse the spectra collected from the aggregation experiments a correction 
needs to be applied to the raw data. The spectrophotometer does not take absorbance 
measurements at each wavelength at the same time, therefore each spectra needs 
correcting to the absorbance value of the sample at the time the first spectrum value was 
taken. In order to perform this correction, the time period for the spectrophotometer to 
take a single scan was recorded across the applicable wavelength range. 
Table 6.1:Time between first data point collection and selected wavelength collection point. 
Wavelength 
/nm 
Time from first collection point /s 
420 0 
400 2.66 
380 5.32 
360 7.98 
340 10.64 
320 13.3 
 
In order to correct the data so that all absorbance values in a spectrum correspond to the 
same time point, values from Table 6.1 were used to correct the raw spectrum data.  
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Figure 6.5: Calculation of corrected absorbance values 
     
(     )(       )
(     )
    
Equation 6.1: Equation for calculation of corrected absorbance. 
Figure 6.5 and Equation 6.1 illustrate the calculation for the corrected absorbance value 
of the second spectra CA2 at y nm. Where x is the time correction value taken from 
Table 6.1, A1 and A2 the absorbance values for the first and second spectra absorbance 
value at y respectively and T1 and T2 the time values for the first and second absorbance 
values at y. This is performed for all absorbance values across each wavelength of each 
spectra. As can be seen from Figure 6.6 which illustrates the full extent of the 
corrections, there is no difference between raw and corrected data at the large 
wavelengths as this is where the absorbance scan begins, however the discrepancy 
becomes larger as the wavelengths get shorter. It is worth noting that this correction 
method assumes a linear change in absorbance between each successive spectra, 
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therefore it is important to have a large number of spectra in an aggregation experiment 
in order to maintain the accuracy in the shape of the absorbance curve. 
 
Figure 6.6: Corrected absorbance spectrum of lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8 
(dotted) compared with raw data values (black). 
The scattering exponent must be determined from these corrected spectra in order to 
determine the particle size. The wavelength dependent scattering follows a power law 
where: 
 ( )      
Equation 6.2 Equation for wavelength dependent absorbance. 
The absorbance A at wavelength λ is given by Equation 6.2 where α is a constant and β 
is the scattering exponent. This exponent can be calculated from the fit of Equation 6.2 
to each spectra or by obtaining a gradient from a plot of log A versus log λ, see Equation 
6.3. 
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   ( ( ))     ( )         ( ) 
Equation 6.3: Scattering exponent calculation in the terms of y=mx+c. 
This scattering exponent is calculated for each spectra obtained within the experiment to 
give a scattering exponent for each time value calculated. An example of such can be 
seen in Figure 6.7. 
 
Figure 6.7: Scattering exponent lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8. at 67.1 ºC 
 Figure 6.7 shows how the scattering exponent has a meaningful value when the 
absorbance in the solution begins to rise. Before the drop in the scattering exponent, 
there is no absorbance or scattering, and so the exponent is zero. The scattering 
exponent begins to rise in conjunction with the rise in absorbance seen in Figure 6.4 and 
will even continue to rise despite the absorbance falling off after reaching a peak. This 
may indicate that there are larger structures present, despite the absorbance tailing off, 
indicating a decrease in concentration. This gives some support to the idea of clustering 
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occurring after the absorbance has reached its peak and particulate aggregate formation 
and growth has occurred. 
The theory section (Chapter 3.4) details how the scattering exponent can be converted in 
to a spherical protein diameter using the refractive indices of the protein and the 
medium. This procedure produces a sixth order polynomial function which allows the 
conversion of scattering exponent to diameter. 
 
Figure 6.8: Diameter versus time plot of lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8. at 67.1 
ºC. Error bars are the size of the points. 
As can be seen in Figure 6.8, the plot shows very similar resemblance to that of Figure 
6.7, except the values of the y axis now represent the diameter values of the protein 
aggregate. It is also worth noting that before the diameter increase there are some 
missing points from the plot. This is a common feature during this part of the plot, 
where the scattering exponent value converts to a negative diameter value which is 
clearly nonsensical. This highlights a limitation within the experiment where the 
smallest sizes detected are around 50-100 nm based on the protein system and can be 
attributed to the constraints of using UV light to probe such small length scales and also 
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the rapid dynamic growth of the system at these time points at length scales below 50 
nm. 
The growth curve in Figure 6.8 grows exponentially before levelling out at a maximum 
diameter value. In order to determine the number of aggregates formed within the 
sample, this maximum diameter value must be accurately determined. This is performed 
by fitting an exponential function to the diameter growth data (Equation 6.4). Where the 
diameter; d at time; t is determined from the maximum diameter dm, a fitting parameter 
d0, and a time constant τ. 
 ( )        
    
Equation 6.4: Fitting function to determine final diameter value. 
 
Figure 6.9 Fit of Equation 6.4 to diameter values of in 100 mM sodium phosphate, 100 mM NaCl pH 5.8 at 67.1 ºC 
0 6000 12000
0
400
800
D
ia
m
e
te
r 
/n
m
Time /s
167 
 
When the fit of the function from Equation 6.4 is applied to the data in Figure 6.8 it can 
be seen that the equation fits very well to the data (Figure 6.9). To ensure a successful 
fit, the data towards the end of the incline was used over that at the start of the 
aggregation process as it leads to a more accurate determination of the final diameter 
than that data at the start of the run, as determined by R
2
 values. 
It is taken that the protein aggregates have reached their maximum size due to total 
depletion of the monomer, therefore all the protein is present within the aggregate. It is 
therefore possible to calculate the number of protein monomers that make up each 
aggregate Anm, assuming each aggregate is identical in size (this is a fair assumption as 
formation of particulate monomers have been seen to have a uniform size distribution 
[4] (Equation 6.5) ). 
     
 
  (
  
 )
 
  
 
Equation 6.5: Calculation of aggregate number for maximum particulate diameter. 
Where Vm is the volume of the protein molecule, calculated using the web program 
VADAR [5], which calculates the volume of a protein molecule from its 
crystallographic structure taken from the PDB [6].  
The maximum aggregate number Anm can then be used to calculate the concentration of 
aggregates Ca present within the sample (Equation 6.6), where Cm0 is the known initial 
concentration of the monomer: 
   
   
   
 
Equation 6.6: Calculation of aggregate concentration 
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With the value for the concentration of aggregates calculated, it is possible to calculate 
the value for the concentration of monomer present at each time value during the 
aggregation process. This is can be calculated from each diameter throughout the time 
course of the experiment. An equation similar to that of Equation 6.5 is used to 
calculated the aggregation number at each time point, An(t), from each diameter d 
(Equation 6.7). 
  ( )   
 
  (
 ( )
 )
 
  
 
Equation 6.7: Calculation of number of monomers in each protein aggregate at each time point. 
 
Figure 6.10: Aggregate number versus time for lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8 at 
67.1 ºC. Error bars are the size of the points. 
Figure 6.10 shows the aggregate number produced for each diameter from Equation 6.7. 
The plot range has been edited to include only viable data, where data from negative 
diameters has been omitted, and also data beyond the peak; where clustering is thought 
to be occurring, has also been removed. Barring omissions and the y-axis scale Figure 
6.10 looks very similar to Figure 6.8, as it is a scaling factor which has been applied to 
the diameter plot. 
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The values generated in Equation 6.7 can be used to calculate the concentration of 
monomer at each respective time point; Cm(t). 
  ( )      (      ( )) 
Equation 6.8: Calculation of monomer concentration at each time point. 
Equation 6.8 is the final step in converting the diameter values into monomer content in 
solution. This allows for a plot of monomer concentration versus time to be produced. 
 
Figure 6.11: Concentration of monomer over time for lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 
5.8 at 67.1 ºC. Sections A,B, and C indicate different regions within the curve. Error bars are the size of the points. 
Figure 6.11 shows the concentration values produced from the example data using 
Equation 6.8. Section A of the data indicates the period of the experiment before 
aggregation. The plot does not show the actual value of the monomer concentration, in 
this case 1.09×10
-4 
M. This is because there is no input value for the diameter, as the 
size of the monomer is too small to be detected using this technique. Section B relates to 
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the formation of the protein aggregate population, where the ever increasing rate is only 
limited by the surface area of aggregates; which is increasing. Section C indicates the 
growth phase of the particulates, where the rate of monomer depletion is decreasing 
over time. Here the rate limiting factor is the concentration of available monomer, as 
this decreases; so does the rate.  
The process of aggregation is usually considered to be a second order reaction, as the 
rate depends on both the concentration of the monomer and the concentration of the 
aggregates. However, in this aggregation process the aggregate concentration is static 
once established (as verified by monodisperse particulate aggregate sizes under SEM 
[4]).  With this, the particulate aggregation process is a pseudo first order reaction and 
therefore can be modelled as such with Section C in Figure 6.11 being fit to a first order 
rate model for the depletion of monomer. This can be seen in Equation 6.9, where kob1 is 
the first order rate constant. 
       
(      ) 
Equation 6.9: First order rate equation for depletion of monomer. 
 
Figure 6.12 illustrates the fit of Equation 6.9 to the growth section of the example 
experiment, where a good fit is achieved. The first order rate constant; kob1 (s
-1
), 
incorporates all factors responsible for the rate of the reaction, including the 
concentration of aggregates. 
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Figure 6.12: Fit of Equation 6.9 (red line) to growth phase of lactoglobulin in 100 mM sodium phosphate, 100 mM 
NaCl pH 5.8 at 67.1 ºC. Error bars are the size of the points. 
     
    
  
 
Equation 6.10: Equation for second order reaction rate calculated from pseudo first order rate. 
Equation 6.10 illustrates how the observed second rate constant kob2 (dm
3
 mol
-1
 s
-1
) can 
be calculated from the observed first order rate and the aggregate concentration ; CA 
(mol dm
-3
). This second order rate relates the change in monomer concentration to the 
aggregate concentration and monomer concentration by Equation 6.11. 
   
  
          
Equation 6.11: Second order rate equation 
It is at this point that the model for particulate protein aggregation is presented, as seen 
in the following equations. 
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Equation 6.12: Particulate protein aggregation pathway [3]. 
Equation 6.12 a illustrates the structural perturbation of the protein that occurs before 
aggregation. N represents the native state of the protein molecule which is in 
equilibrium with an aggregation prone conformation of the protein; an intermediate 
state; I. Both the forward and reverse reactions have rate constants associated with this 
initial process. Equation 6.12 b represents the nucleation of particulate aggregates where 
two aggregation prone intermediates combine to form the smallest possible aggregate; 
A2. This is governed by a separate rate constant; k3. Aggregate growth by intermediate 
monomer addition is shown in Equation 6.12 c where single intermediates add on to the 
aggregate to produce a larger aggregate. Again this has its own rate constant associated 
with it; k4. Once the monomer is depleted, additional aggregation can be seen to take 
place in the form of aggregate clustering highlighted in Equation 6.12 d. This leads to 
the clustered spherical morphology of aggregates seen under SEM [4] This was 
confirmed using ESEM to view aggregates produced from the UVLSS process (Figure 
6.13, which illustrates spherical cluster-like nature of the final aggregates. 
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Figure 6.13: ESEM image of BSA aggregates produced at 76 ºC at 2.84Torr. 
Step b is considered to be a rapid process [7] which occurs prior to step c dominating 
the aggregation. This formation of aggregates takes place only over one short time span, 
as can be seen by particulate aggregates all being of similar size [4]. Therefore this 
process is not occurring over the growth period, though it does contribute by producing 
the aggregate concentration, which after step b remains constant. Step c can be 
modelled using the current data ranges collected here as the rate of monomer 
consumption can be followed. Step d is observed within this experiment (Figure 6.4), 
but this data is hard to model due to the irregular shapes and sizes formed from this 
process. This data range is therefore omitted from the analysis. Therefore over the 
selected data range, there are 3 rate constants determining the overall rate of the 
process; k1, k2, and k3. 
In order to model the reaction rates occurring in this process, two rate limiting cases 
were considered; unfolding limited aggregation and association limited aggregation. 
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Unfolding limited aggregation would require step c to be of a much larger magnitude 
than step a, hence: 
             
Equation 6.13: Unfolding limited aggregation rates. 
Using Equation 6.13 and Equation 6.12 it can be seen that the formation of any 
intermediate is converted into particulate aggregates, and does not return to N. Any 
monomer present within the system can be assumed to be in the native state as any 
intermediate will be instantly consumed. Therefore the model is reduced to a first order 
rate equation: 
   
  
      
Equation 6.14: Rate equation for unfolding limited aggregation. 
Using Equation 6.14, the rate of monomer consumption would relate to the rate of 
native monomer unfolding to intermediate. 
Association limited aggregate would produce the reverse of Equation 6.13, where step a 
is more rapid than step c, therefore: 
            
Equation 6.15: Rates for association limited aggregation. 
Equation 6.15 illustrates that the monomer will be present as both native and 
intermediate states. Therefore in association limited aggregation an equilibrium exists 
between the native and the intermediate state: 
          
Equation 6.16: Association limited aggregation equilibrium. 
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The equilibrium constant; K, can be described as a ratio between the rates of both the 
forward and reverse reactions (Equation 6.17). 
  
  
  
 
Equation 6.17: Equilibrium constant equation. 
The total monomer within this system is the sum of both the concentrations of native 
and intermediate states (Equation 6.18). 
         
Equation 6.18: Calculation of total monomer. 
The previous three equations (Equation 6.16, Equation 6.17, Equation 6.18) can be 
combined to give the concentration of monomer in terms of the concentration of 
intermediate, and the equilibrium constant. 
   (   )
  
 
 
Equation 6.19: Calculation of monomer concentration from intermediate concentration and equilibrium constant. 
In the association limited aggregation kinetics the resultant model is a second order rate 
equation, which is dependent on the concentration of both aggregate, and intermediates 
(Equation 6.20). 
   
  
        
Equation 6.20: Second order rate equation for association limited aggregation. 
However, the concentration of the intermediate cannot be easily determined as the 
experimental results only produce information on the monomer as a whole (i.e native 
and intermediate). Therefore Equation 6.19 can be substituted into Equation 6.20 in 
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order to put the second order rate equation in terms of both monomer and aggregate 
concentrations (Equation 6.21). 
   
  
 
       
(   )
 
Equation 6.21: Second order rate equation for association limited aggregation in terms of aggregate and monomer 
concentration. 
By comparing Equation 6.11 and Equation 6.21 it is possible to relate the observed 
second order rate constant to the equilibrium constant and the association rate constant. 
  
    
(       )
 
Equation 6.22: Determination of  equilibrium constant from observed second order rate constant. 
In Equation 6.22 it is assumed that the association rate constant k4 is independent of 
temperature. This is a reasonable assumption given that the intermediate monomers are 
so highly reactive due to the large areas of unfavourable hydrophobic patches present on 
the surface of both the monomer and the aggregate [8]. This would result in the 
activation energy between monomer and aggregate being negligible. The relationship 
between the equilibrium constant and the absolute temperature; T, can be described by 
Equation 6.23. 
          
Equation 6.23: Calculation of standard free energy change. 
Where R is the gas constant and ΔG is the standard free energy change. This can then be 
utilised to determine the best fit value for k4 across a data range. The initial value for k4 
was chosen as a value above the largest value of kob2 so that the logarithmic term 
produced a real value and then iterated to find the largest R
2
 value for k4. From Figure 
6.14 it can be seen that the R
2
 fit value increases as k4 increases, but the rate of increase 
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decreases exponentially. In order to counter this, two straight lines were fitted to the 
extremes of the plot, and their intercept used to determine a k4 value at which there is 
minimal increase in R
2
 value with increasing k4. 
 
Figure 6.14: Determiniation of K4 value for lactoglobulin in 100 mM sodium phosphate, 100 mM NaCl pH 5.8. 
The k4 value obtained represents the frequency factor as the activation energy is 
assumed to be zero and therefore can be compared to literature values.  
The temperature sensitive portion of Equation 6.22; K can be described in terms of 
Equation 6.24: 
  ( )  
  
 
 
  
  
 
Equation 6.24: Calculation of equilibruim constant in terms of entropy and enthalpy. 
Where ΔS is the entropy change for the process (J mol-1 K-1) and ΔH is the enthalpy 
change for the process (J mol
-1
). The entropy value indicates the extent of order or 
disorder created by the aggregating protein on itself and the surrounding water 
molecules. The enthalpy values indicate the energy release or uptake from bonds 
y = 1E-09x + 0.7235 
y = 2E-11x + 0.9225 
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formed and broken. Fitting this equation to the temperature range of data yields values 
for both ΔS and ΔH, which can be compared to literature values. 
Finally it is possible to extract the fraction of protein present in the perturbed 
intermediate state; X, based on a rearrangement of Equation 6.19: 
  
  
  
  
 
(   )
 
Equation 6.25: Calculation of fraction of monomer in perturbed state. 
Equation 6.25 allows for the fraction of perturbed monomer to be plotted at each 
temperature value, and would yield results that can be comparable to the literature 
values for melting temperatures of the protein. These values will be compared later in 
the chapter. 
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6.4 Behaviour Across Protein Systems 
Krebs et al. [4] show how the formation of particulate aggregates is a generic form of 
aggregation that occurs across a number of protein systems. In order to confirm 
similarities in the kinetics of particulate formation, three proteins from the paper were 
studied; β-lactoglobulin, BSA and horse heart myoglobin. 
 
Figure 6.15: Aggregate diameter against time plot for lactoglobulin at 72.0 ºC (open squares) 70.2 ºC (closed squares) 
68.5 ºC (open diamonds) and 66.9 ºC (closed diamonds). Error bars are the size of the points. 
Diameter and concentration plots over time are the simplest plots that give some insight 
into the aggregation process occurring with these three separate proteins. Selected 
temperature aggregation runs for each protein are presented to illustrate the comparisons 
across the protein systems, and are representative of the whole data series. All data has 
been normalised to the time aggregation is first detected. 
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Figure 6.16: Concentration against time plot for lactoglobulin at 72.0 ºC (open diamonds) 70.2 ºC (closed diamonds) 
68.5 ºC (open squares) and 66.9 ºC (closed squares). Error bars are the size of the points. 
 
Figure 6.17: Diameter versus time plot for BSA at 72.6  ºC (closed diamonds) 70.2 ºC (open diamonds) 67.5 ºC 
(closed squares) 65.5 ºC (open squares). Error bars are the size of the points. 
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Figure 6.18: Concentration against time plot for BSA at 72.6 ºC (closed diamonds) 70.2 ºC (open diamonds) 67.5 ºC 
(closed squares) 65.5 ºC (open squares). Error bars are the size of the points. 
 
Figure 6.19: Diameter of myoglobin aggregates against time at 67.3 ºC (closed diamonds) 64.7 ºC (open diamonds)  
63.0 ºC (closed squares) 62.2 ºC (open squares). Error bars are the size of the points. 
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Figure 6.20: Concentration of myoglobin monomer over time at 67.3 ºC (black) 64.7 ºC (red) 63.0 ºC (green) 62.2 ºC 
(blue). Error bars are the size of the points. 
Figure 6.15 illustrates the growth of the β lactoglobulin aggregates. The smallest 
aggregate size which appears to be detected is around the size of 160 nm, however at 
the higher temperature of 72 ºC this value is larger, which is probably due to the rapid 
nature of the aggregation at this temperature. The higher temperatures exhibit 
characteristics of the growth phase of the particulate aggregates as the rate of growth 
decreases over time. At the lower temperature of 66.9 ºC initially there is some 
indication that the rate of aggregate growth is increasing; at this stage the limiting factor 
is not the monomer concentration (as in the growth in higher temperature plots seen 
within Figure 6.15), but the surface area of the aggregates. As more monomer combines 
to the aggregate the surface area increases and during the linear section of the plot a 
transition occurs in the limiting factor of the process, and the exponentially decreasing 
growth rate is observed. This effect is more prominent in the aggregate diameter plots of 
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BSA (Figure 6.17), where across there is some evidence of this transition across a range 
of temperatures. On the other hand, myoglobin (Figure 6.19) shows only the sign of 
monomer concentration being the rate limiting factor in aggregation, across all 
temperatures. 
The monomer concentration profiles of the proteins (Figure 6.16, Figure 6.18, Figure 
6.20) show the rate of monomer depletion increases with increasing temperatures.  
Concentration plots tend to be comparable with their counterpart diameter plot in terms 
of change in initial rate. All plots have an exponential curve and are tending towards a 
zero concentration of monomer. As this data is limited to the growth phase of the 
aggregates and data beyond points is considered to be part of the aggregate clustering 
process; the data indicates that clustering only commences when there is very little 
remaining monomer in solution. There appears to be an exception to this in Figure 6.18 
(open diamonds), but in general this appears to be generic across all the evaluated 
ranges. 
It is worth noting that the myoglobin plots display some deviation between points 
(Figure 6.19 and Figure 6.20). This is due to the wavelengths required to probe the 
structure of the myoglobin (as discussed in the methods section). As a result of the low 
scatter produced at these wavelengths, there is a significant size of deviation in the data; 
therefore a large number of data points were collected in order to gain an accurate 
representation of the myoglobin system. 
At each temperature, the aggregate diameter plots converge upon a final diameter size 
once the entirety of the monomer is consumed. These final diameters, fitted using 
Equation 6.4 were plotted against temperature to see if there was any correlation. 
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Figure 6.21: Final aggregate diameter of lactoglobulin aggregates 
 
Figure 6.22: Final aggregate diameter of bovine serum albumin aggregates. 
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Figure 6.23: Final aggregate diameter of myoglobin aggregates. 
 As the final aggregate diameter plots show (Figure 6.21, Figure 6.22, Figure 6.23) there 
appears to be no correlation between temperature and maximum diameter of the 
aggregate. These results appear to disagree with the findings from Krebs et al. [4] which 
show that at higher temperatures, smaller aggregates are formed as there are more 
nucleation sites over which the remaining intermediate monomer is spread. The results 
appear to show that the nucleation process is independent of temperature, and as 
aggregate concentration and final diameter size are proportional; temperature has no 
effect on either (Figure 6.24). Considering the model for particulate aggregation 
(Equation 6.12), this indicates that the initial nuclei are of similar sizes which could 
indicate that the extent of unfolding within the protein molecules are similar across this 
temperature range and that further unfolding does not occur. 
The maximum diameters of each protein vary; β-lactoglobulin has an average final 
diameter of around 670 nm, whilst BSA is 500 nm and myoglobin 900 nm. Here there 
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appears to be a trend between the size of the native protein monomer and its final 
aggregate diameter, as  myoglobin is the smallest of the three, whilst BSA is the largest 
[6]. 
 
Figure 6.24: Aggregate concentration against temperature for lactoglobulin (open diamonds) BSA (full squares) and 
myoglobin (full diamonds). Error bars are omitted for clarity, but still indicate no trend. 
In order to assess the viability of both the unfolding and association limited aggregation 
models, Arrhenius plots were applied to the extracted rate constants for each data range 
for the three proteins. The Arrhenius equation (Equation 6.26) relates the temperature 
dependence of the rate constant; K, by a frequency factor, or collision rate; A.  
     
  
   
Equation 6.26: Arrhenius equation. 
Arrhenius plots of lnK against 1/T would yield a gradient of –Ea/R and intercept ln(A), 
which would give the frequency factors for aggregation in the three systems. 
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Figure 6.25: Arrhenius plot for the unfolding limited aggregation model for lactoglobulin. 
 
Figure 6.26: Arrhenis plot for the unfolding limited aggregation model for BSA. 
 
Figure 6.27: Arrhenius plot for unfolding limited aggregation model in myoglobin 
The above figures (Figure 6.25, Figure 6.26, Figure 6.27) illustrate the Arrhenius fit to 
the unfolding limited aggregation model. All three lines show a reasonable fit to a 
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straight line, in which K is proportional to the absolute temperature. Respective R
2
 
values are 0.857, 0.831, and 0.752 indicating a reasonable level of fit across the 3 
proteins. However, the values produced for the frequency factor from these plots are: 
4.38×10
55 
s
-1
, 1.97×10
47 
s
-1
, and 1.37×10
28 
s
-1
. These values are significantly larger than 
any realistic values seen elsewhere in the literature, where first order small molecule 
reactions are at most in the region of 10
17 
s
-1
 [9].  
 
Figure 6.28: Arrhenius plot for the association limited aggregation model for lactoglobulin. 
 
Figure 6.29: Arrhenius plot for the association limited aggregation model for BSA 
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Figure 6.30: Arrhenius plot for the association limited aggregation model for myoglobin 
Arrhenius plots for the association limited aggregation of the proteins are illustrated 
above (Figure 6.28, Figure 6.29, Figure 6.30).  There appears to be a moderately 
increased fit to the straight line trend over the unfolding limited aggregation, with R
2
 
values reported at; 0.867, 0.873 and 0.9059 respectively. However the reported 
frequency factors of the second rate reaction are also unreasonably high: 1.31×10
57 
s
-1
, 
4.9×10
47 
s
-1
, and 9.3×10
58 
s
-1
. This illustrates the Arrhenius plot may not be the most 
valuable way of modelling this data in order to present meaningful values. 
The frequency factor for association; K4 can be obtained by varying its value to obtain 
the best fit for the equilibrium between native and intermediate (Figure 6.14, Equation 
6.22).  
Table 6.2:Reported K4 values for the three proteins. 
Protein K4 Value /dm
3
mol
-1
s
-1 
Β-Lactoglobulin 7.27×108 
BSA 5.60×10
7
 
Myoglobin 1.07×10
9
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Table 6.2 illustrates the change in K4 values for each protein. These values appear to 
give a much more sensible value for the collision rate for each protein. There also 
appears to be the trend that the smaller the protein, the more frequent the collisions. 
The fitted value of K4 allows the fraction of intermediate present at each temperature to 
be elucidated (Figure 6.31, Figure 6.32, Figure 6.33). These plots give an indication of 
the equilibrium shift at each temperature. 
 
 
Figure 6.31: Intermediate fraction against temperature for lactoglobulin. 
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Figure 6.32: Intermediate fraction against temperature for BSA. 
 
 
Figure 6.33: Intermediate fraction against temperature for myoglobin aggregates. 
The lines indicated on these plots are lines of best fit produced from the values for ΔH 
and ΔS of the unfolding process. The associated values are presented in Table 6.3. 
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Table 6.3: Calculation of Gibbs free energy data. 
 β-Lactoglobulin BSA Myoglobin 
ΔH / kJmol-1 492 ±28 709 ±55 514 ±50 
ΔS / Jmol-1K-1 1411 ±79 2075 ±162 1496 ±145 
T at ΔG =0 /K 348.8 342.1  343.7 
 
Table 6.3 shows the extracted information on the melting temperatures and stabilities 
and can be compared to literature values for the unfolding of each protein. 
The melting temperature of β-lactoglobulin produced from the unfolding model agrees 
well for quoted values of the unfolding temperature of the protein of 348.8 K [10]. 
Additionally the quoted value of 492 kJmol
-1
 shows some agreement with the reported 
value here, and the discrepancy may be explained by the difference in pH value between 
the two experiments; where the value reported here is obtained in more stable 
conditions [11]. 
The value presented here for the melting temperature of myoglobin shows good 
agreement with that seen in the literature [12]. Additionally the ΔH values show 
agreement with trends seen in studies of oxidated forms of myoglobin and 
microcalorimetric measurements performed on the sperm whale variant of the protein 
[13, 14]. 
The melting temperature for BSA of 342.1 K is marginally higher than the reported 
values from DSC studies [15, 16], but following the trend of increased stability at pH 
closer to the protein isoelectric point, this value shows good agreement. Additionally 
the ΔH values for unfolding bear good agreement, with reported values here being 
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marginally larger. This again can be attributed to the increased stability at this studied 
pH. 
Similarly to the ΔH values the entropy values are high for proteins of a larger size 
(Table 6.3). These positive entropy values indicate that during the unfolding the protein 
is tending towards disorder. This can be explained by the interaction of both polar and 
non-polar residues with the water molecules, where there are more non-polar residues 
imposing a disorder on the surrounding molecules than polar residues creating order. 
This appears acceptable as the majority of hydrophobic residues are buried in the 
protein fold, therefore there are more to be exposed when the protein unfolds. 
Additionally, the trend between size and entropy change can be attributed to more 
hydrophobic residues in the larger proteins disordering more water molecules than that 
of the small proteins. 
6.5 Effect of Tween on Aggregation 
The UVLSS technique can be used to assess the effect of additives on the aggregation 
rate of proteins. Tween 20 is an additive often used within protein buffers to increase 
the yield of native protein produced [17]. Tween 20 has also been shown to reduce the 
aggregation, however the mechanism for this is not clear [18, 19]. In these instances 
0.01 % Tween 20 w/v was included in the aggregation buffer and comparisons made to 
elucidate the effect and mechanism of Tween 20 on particulate aggregation. 
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Figure 6.34: Comparison of final diameters of aggregates in BSA and lactoglobulin both with and without Tween 20. 
Figure 6.34 compares the range of diameters produced in two protein systems with and 
without Tween. As has been previously shown, the final size of the aggregate does not 
appear to be determined by the temperature, therefore the diameters and their 
distributions can be represented by box plots. Figure 6.34 illustrates that both BSA and 
lactoglobulin aggregate sizes are not affected by the presence of Tween 20.  There 
appears to be a slightly larger distribution of sizes across the Tween data sets, but this 
distribution difference is mainly insignificant. It can be inferred from these plots that the 
interaction of Tween with these aggregates introduces no new levels or porosity into the 
aggregates, or indeed change the concentration of aggregates formed significantly. 
Therefore it seems Tween has little relevance in the nucleation stages of the aggregate 
formation. 
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Table 6.4: K4 Comparison between protein without additives and protein with Tween 20. 
Protein Native K4/ s
-1
 K4 +0.01 % Tween / s
-1
 
Β-Lactoglobulin 7.27×108 1.24×108 
Bovine Serum Albumin 5.6×10
8
 2.95×10
8
 
As can be seen in Table 6.4, the effect of Tween has some impact on the collision rate 
constant K4. Although this may be within error, this could be accounted for due to the 
interference from the Tween in some collisions, which may reduce the rate slightly. 
Tween has been shown to bind hydrophobic regions within the molten globule of a 
protein [18]. This indicates that the Tween 20-protein interactions compete with the 
protein-protein interactions to reduce the collision rate, as is shown by the decreased K4 
values in Table 6.4. 
 
Figure 6.35: Intermediate fraction against temperature of B-lactoglobulin without additive (closed diamonds) and 
with 0.01 %Tween (open diamonds) 
Figure 6.35 illustrates the effect that Tween has on the equilibrium between native and 
aggregation prone intermediate. It is clear that β-Lactoglobulin with Tween (open 
diamonds) causes a shift in the temperatures at which the intermediate is formed. The 
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shapes of the transition curves indicate that the shift in initial formation is only of the 
size of around 3 degrees. However for full transition of the entire sample from native to 
unfolded is of the order of 10 degrees. This illustrates that whilst the protein is natively 
folded, Tween 20 plays a small role in enhancing the unfolding of β-lactoglobulin, 
however as the transition occurs Tween appears to further enhance the unfolding of the 
protein. This increase in effect correlates with an increasing amount of hydrophobic 
structure available on the protein through which Tween may facilitate the unfolding 
[18]. 
 
Figure 6.36: Intermediate fraction against temperature of BSA without additive (closed diamonds) and with 0.01 
%Tween (open diamonds) 
Figure 6.36 compares the effect of 0.01 % Tween on BSA. Despite the initial formation 
of the intermediate forming at the same temperature ~336 K, there appears to be little 
increase in this across the temperature scale until ~345 K, where the full sample of 
protein is present as intermediate fraction, which is at a similar temperature as that of 
the protein without additive. 
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As in Figure 6.35, the exposure of hydrophobic regions within the protein does appear 
to facilitate the binding of Tween to stimulate the unfolding, however it can be seen that 
BSA in Tween is infact more stable at the lower temperatures as illustrated by the curve. 
          
Equation 6.27:Calculation of Gibbs free energy 
Using Equation 6.27 the Gibbs free energy of the protein at room temperature can be 
calculated. This illustrates the stability of the proteins under conditions with and without 
Tween 20. Table 6.5 illustrates how at 25 ºC proteins in 0.01 % Tween clearly have a 
higher stability that the proteins without. The increase is seen as 2 to 3 fold larger in the 
ΔG values, and indicates why Tween 20 is a competent stabilising additive of the native 
state. 
Table 6.5: Comparative ΔG values of proteins with and without Tween at 25 ºC. 
Protein Native ΔG at 25 ºC /kJ ΔG in 0.01 % Tween /kJ 
BSA 91.5 ±7.14 348.3 ±32.7 
Lactoglobulin 78.7 ±4.4 147.2 ±14.2 
 
6.6 The Effect of Sodium Chloride Concentration  
Sodium chloride is a common additive in protein stabilising solutions [20]. Using the 
UVLSS technique it is possible to investigate the effect that varying concentrations of 
sodium chloride may have on the protein aggregation process. For this study β-
lactoglobulin was chosen as it is a well characterised system in protein aggregation, and 
from previous work within this chapter it can be seen that the formation of β-
lactoglobulin aggregates can be coherently studied by this technique. 
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Figure 6.37: Absorbance at 320 nm of β-lactoglobulin heated to 70.8ºC at pH 5.8 sodium phosphate buffer including 
150,100 mM and 50 mM sodium chloride concentrations. 
Figure 6.37 offers a primitive method for examining the effect of sodium chloride 
concentration on the aggregation of β-lactoglobulin. All three samples were recorded to 
have an average temperature of 70.8 ºC during the isothermal stage. At the highest of 
salt concentrations, the absorbance can be seen to increase at an earlier time than that of 
a lower salt concentration.  This indicates that aggregation is occurring earlier in the 
more concentrated salt environment, which may suggest the high salt concentration 
contributes to a destabilising effect to the native protein conformations. 
Figure 6.38 illustrates the range of final aggregate diameters produced by each 
experiment at the three salt concentrations. It can be seen that there is no substantial 
deviation in the final diameter of aggregates across the concentration range, similar to 
the results seen for the additive Tween (Figure 6.34). The sole trend within the box plots 
of Figure 6.38 is that the range increases in line with the salt concentration. This may be 
attributed to the speed at which the experiments take place at the higher salt 
concentration, therefore the degree of error in determining the final concentration may 
be larger. 
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Figure 6.38: Comparison of final aggregate diameters for b-lactoglobulin aggregates in 50 mM, 100 mM and 150 mM 
salt conditions. 
 
Figure 6.39: Intermediate fraction versus temperature for β-lactoglobulin at 50 mM (open diamonds), 100 mM (open 
squares) and 150 mM (closed squares) NaCl concentrations. Lines of best fit are applied to each. 
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Figure 6.39 shows the effect the concentration of NaCl has on the aggregation 
behaviour of β-lactoglobulin. Clearly higher concentrations have a destabilising effect 
on the native monomer, as the transition appears to be more rapid and at a lower 
temperature.  
Table 6.6: Values for lactoglobulin aggregation thermodynamics values. 
 
Lactoglobulin with NaCl concentration 
50 mM 100 mM 150 mM 
ΔH /kJ 462 ±49 492 ±28 788 ±72 
ΔS / kJK-1 1.3 ±0.14 1.4 ± 0.14 2.3 ±0.21 
Temperature at 
ΔG=0 /K 
355.2 348.8 347.3 
ΔG at 25 ºC 81 ±8.6 78.7 ±4.4 123 ±11.3 
 
Both values for ΔH and ΔG at 25 ºC indicate that salt plays a stabilising role in the 
protein structure (Table 6.6), where at higher salt concentrations, a much larger amount 
of energy is required to unfold the protein than at lower salt concentrations. However, 
this further results in the protein at higher salt concentration, resulting in an 8 ºC change 
in unfolding temperature over the 100 mM NaCl range. This appears to show a similar 
trend to that of the Tween 20 experiments (Table 6.5). The effect of salt on aggregation 
is also examined in the following section, therefore the overall effect of salt on 
aggregation will be discussed in the concluding chapter. However it is worth noting that 
an increase in salt concentration from 50 mM to 150 mM decreases the K4 value from 
2.9×10
9 
s
-1
 to 4.4×10
8 
s
-1
and therefore clearly plays a role in decreasing the number of 
successful collisions during the aggregation process. 
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Chapter 7 : Aggregate Formation in Refolding 
7.1 Introduction 
The presence of aggregates during protein refolding is a major issue. Aggregate 
formation results in lower yield of native proteins produced in the refolding process [1], 
and when present in therapeutic use, the presence of aggregates is capable of producing 
immunogenicity and loss of therapeutic function of the protein [2]. 
Whilst many items in the literature focus on monitoring the yield of native protein 
produced [3, 4], few analyse the formation of aggregates [5]. Work presented here aims 
to relate the presence of the molten globule state during refolding to the formation of 
aggregates of the small alpha helical protein cytochrome C. Furthermore, the effect of 
both sodium chloride concentration, and final denaturant concentration are investigated. 
This is performed using stopped flow anisotropy, absorbance, and the use of the 
fluorescent probe; ANS. 
7.2 Experimental Overview 
A stopped flow cell, capable of measuring absorbance, fluorescence and fluorescence 
anisotropy was used to measure the refolding of protein that occurred when solutions 
from two syringes were mixed. One syringe contained unfolded protein in a high 
concentration of denaturant, the other contained buffer. Upon mixing the denaturant is 
diluted and the protein refolds. The refolding conditions are altered either by changing 
the sizes of the syringes that feed the mixing chamber, therefore determining the final 
urea concentration, or changing the salt concentration present in the diluting buffer. The 
aforementioned experimental techniques are then used to probe the behaviour of the 
protein whilst folding over a 100 second time period. 
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7.3 Folding Characteristics 
 
Figure 7.1:  The fluorescence emission of ANS present with cytochrome C and 8 M urea during a 1:10 dilution with 
100 mM TRIS 0 mM NaCl pH 10.6 refold buffer. The dashed line indicates the initiation of mixing at 0 s. Before 0 s 
indicates the fluorescence of the ANS sample. 
Figure 7.1 illustrates the refolding of Cytochrome C in terms of hydrophobic exposure. 
ANS is present in one of the syringes with the Cytochrome C, maintained in the 
unfolded state with 8 M urea. The ANS molecules may bind to the exposed 
hydrophobic regions present on the protein and produce an increased fluorescence (over 
the unbound ANS molecules) when excited at 370 nm [6]. The fluorescence value of 
this sample alone is indicated by the values for time zero in Figure 7.1. However, upon 
initiating the stopped flow reaction, the fluorescence signal is instantly reduced to a 
lower fluorescence level. 
This finding indicates that the hydrophobic collapse of the protein occurs within the 
dead time of the instrument, where the presence of a much diluted concentration of urea 
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no longer presents a barrier to folding; the energetically favourable elimination of water 
and ANS from these regions is rapid. This appears consistent with current 
understanding where even large multidomain proteins accomplish hydrophobic collapse 
in the nanosecond timescale [7], and proteins such as cytochrome C begin structural 
formation of elements of secondary structure even within the deadtime of this 
experiment [8, 9]. The small fluctuations seen in the ANS fluorescence in Figure 7.1 is 
assigned to low level aggregation occurring, and will be discussed in detail later in this 
chapter. 
 
Figure 7.2: Fluorescence Anisotropy over time for Cytochrome C in 8 M Urea refolded at 1:25 ratio at 280 nm. 
Figure 7.2 illustrates the corresponding fluorescence anisotropy values collected for the 
folding experiments in Figure 7.1. Fluorescence anisotropy corresponds to the mobility 
of the fluorophores present within the protein [10], namely; phenylalanine, tyrosine and 
tryptophan. At 280 nm the majority of the fluorescence will appear from the tyrosine 
and tryptophan residues, with tryptophan fluorescence dominating the signal [11]. 
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In contrast to Figure 7.1, Figure 7.2 shows some change in the anisotropy signal during 
the folding process, indicating that there is some detectable structural change occurring 
throughout this time period. The change in anisotropy value from a lower to higher 
value is representative of the fluorophores within the protein becoming less mobile.  
During the first 10s this change in mobility is drastic, with an additional 20s of small 
change in mobility before the mobility of the fluorophores remains constant throughout 
the remainder of the experiment. 
From Figure 7.1 and Figure 7.2 it can be seen that the folding of Cytochrome C is not 
an instant process, and that although the hydrophobic collapse of the protein is clearly in 
the sub microsecond time span (which is a widely accepted result during protein folding 
[12] [13]), the structural rearrangement of at least the fluorescent residues occurs over a 
much greater time span. This may be indicative of the molten globule state of the 
protein; where the hydrophobic core of the protein structure is formed [14], but there is 
still some mobility in some outer residues as they adopt their energetically favourable 
conformations. This mobility may be representative of the unquenched Trp 59 residue 
which has been suggested to remain loosely packed until the late stages of cytochrome 
C folding [15]. 
This residue mobility measured by fluorescence anisotropy during refolding is not 
unique to cytochrome C, and is evident across a number of protein systems. 
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Figure 7.3: Anisotropy of refolding of proteins in 8M urea at a ratio of 1:10 at 280nm. From top to bottom 
:Ribonuclease A(100mM sodium phosphate buffer at pH 7.8),β-lactoglobulin(100mM TRIS at pH 7.8), α-
lactalbumin(100mM TRIS at pH 7.8) 
 
Figure 7.3 shows the anisotropy for refolding of different protein systems at 280 nm. 
All three figures show some agreement with the findings shown in Figure 7.2; that 
fluorophore mobility is present over a timescale of tens of seconds. These refolding 
timescales appear to vary somewhat across the systems, however the general form of the 
anisotropy plot is the same across proteins. This suggests that this is a ubiquitous stage 
in protein refolding. It may be worth noting that in both β-lactoglobulin and α-
lactalbumin folding, the proteins achieve a slightly over rigid formation, indicated by a 
minor crest in the anisotropy plots at 20s into the duration of the experiments before 
relaxing into the stable structure.  
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It may be further noted that these comparative proteins differ from cytochrome C in that 
they contain sulphide bridges, which will not be disrupted by the high concentrations of 
denaturants within the solution, therefore the starting state of the protein before mixing 
cannot be considered as totally unfolded protein. The presence of disulphide bridges 
should provide some template for folding and increase the chance of the protein 
adopting its native structure. This should have minimal bearing on the molten globule 
state of the proteins however, aside from curtailing the time period before it appears. 
Ribonuclease A (Figure 7.3) has been shown capable of undergoing both rapid and slow 
refolding to produce the native state [16]. Under these experimental conditions, it can be 
clearly seen that fluorophore mobility does not become stable until ~30s which may 
relate to the mobility of two tyrosine residues measured in the refolding of ribonuclease 
A by real time NMR [17]. 
β-lactoglobulin forms a compact globular structure which is marginally (10 %) larger 
than the native state within the first 100ms of refolding [18]. The data in Error! 
Reference source not found. suggests that under these conditions, the final structural 
compaction occurs over a much larger timescale (~30s). This appears concurrent with 
findings from elsewhere [19], that suggest that once the secondary structure has formed 
within the rapid time span, the protein maintains a molten globule like structure, which 
is what Error! Reference source not found. characterises. 
The molten globule state of α-lactalbumin appears to have a shorter existence (~20s) 
under these conditions than the other proteins (Figure 7.3). The existence of its molten 
globule state may have been lengthened by the absence of a metal cofactor which would 
aid the rate of refolding [20]. Taking this factor into account the molten appearance of 
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the molten globule state does appear to agree with related work on the refolding of α-
lactalbumin where tryptophan fluorescence was seen to be quenched after ~10s [21]. 
These figures clearly show that fluorophore mobility, or molten globule state, is present 
well after the hydrophobic collapse and secondary structure formation under these 
refolding conditions, and appears to be a common feature across proteins. 
7.4 Aggregation produced from folding 
 
Figure 7.4: Refolding of cytochrome C at a 1:10 ratio followed by fluorescence anisotropy at 280 nm (solid) and 
absorbance at 320 nm (dotted) line. 
The emergence of protein aggregates within the stopped flow sample can be measured 
by the absorbance of light at 320 nm [22]. This was undertaken alongside anisotropy 
and ANS probing of the refolding of cytochrome C (Figure 7.4). It can be seen that a 
small amount of aggregation takes place during the refolding process. At time 0, there is 
already a presence of aggregates, as can be noted by the small absorbance value at time 
0 in Figure 7.4. As the absorbance is baselined to the unfolded sample of cytochrome C, 
this represents a production of aggregates during the dead time of the instrument, during 
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the hydrophobic collapse of the protein structure. The absorbance graph then represents 
an increasing rate of aggregation; either in aggregate number or size, before this growth 
subdues exponentially.  
The high rate of growth appears to concur with the protein being still in a mobile state, 
however growth still occurs; albeit more slowly when the protein has adopted its rigid 
structure. Clearly whilst the protein is in the molten globule state it requires some side 
chain packing in order to stabilise it as might be expected [23], otherwise as Figure 7.4 
shows, it has a tendency to aggregate. Furthermore, this increase in aggregation 
continues whilst the protein is in its rigid form, indicating that the aggregates may be 
inducing the native protein into an aggregate prone conformation, a behaviour that has 
been observed in other protein aggregate systems [24]. 
 
Figure 7.5: Absorbance of cytochrome C at 320 nm during refolding at 1:10 ratio into 100 mM Tris buffer containing 
0 mM NaCl (full line) 250 mM NaCl (dashed line) and 500 mM NaCl (dotted line). 
One of the most common methods for reducing aggregation during refolding is to use 
NaCl concentrations [25]. As can be seen from Figure 7.5, increasing salt 
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concentrations does have this effect on cytochrome C. It can be seen that the initial 
formation of aggregates is lower by comparison of values at t=0 for refolding taking 
place at higher NaCl concentrations. This higher concentration appears to prevent the 
increase in aggregate formation for a substantial period of time, and results in smaller 
absorbance values seen over the 100s period investigated here. The presence of salt 
appears to prevent aggregation occurring whilst cytochrome C is in its most mobile 
state, however growth appears to accelerate whilst the protein is closer to its native state 
(Figure 7.6). This growth continues whilst the protein appears to hold its rigid structure, 
again indicating that the native protein is being induced to aggregate by existing 
aggregates. 
 
Figure 7.6: Absorbance at 320 nm (dashed line), and anisotropy at 280 nm (solid line) of Cytochrome C refolded at 
1:10 into Tris containing 250 mM NaCl. 
Additionally, the effect of final denaturant concentration on aggregation during 
refolding was investigated. This was achieved using different ratios of unfolded protein 
to refolding buffer. The effect of these ratios at a high concentration of NaCl is shown 
in Figure 7.7.  
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Where the concentration of urea is high (i.e a 1:5 ratio), it can be seen that there is 
minimal increase in aggregation, and the rapid growth rate which is seen at any of the 
1:10 ratios (Figure 7.5) is not present. Here the high concentration of urea must be 
preventing protein-protein interactions which would increase aggregation.  
 
Figure 7.7: Absorbance at 320 nm of Cytochrome C refolded at 1:5 (solid line) , 1:10 (dotted line), 1:25 ( dashed 
line). 
 
Figure 7.8: Anisotropy at 280 nm of Cytochrome C in 8 M urea unfolded at 1:25 ratio (solid line) 1:10 ratio (dotted 
line) 1:5 ratio (open dots). 
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At the low concentrations of urea (i.e 1:25 ratio) the rapid growth section of the 
aggregates is even steeper than that seen at 1:10 ratio, with minimal lag phase after the 
hydrophobic collapse before a rapid increase in aggregates begins. It is worth noting 
from Figure 7.10 that the rapid increase also occurs during the timeframe where the 
protein is at its most mobile, and again the growth continues whilst the protein appears 
to be in the rigid native state. Figure 7.7 clearly shows that a higher step dilution of urea 
concentration results in increased levels of aggregation rather than just the levels of non 
native protein, and indicates that stepwise urea dilutions should indeed increase the 
yield from refolding [26, 27]. 
Fluorescence measurements performed on the refolding products of cytochrome C at the 
3 ratios indicate a difference in the quality of folding at each ratio. 
 
Figure 7.9:Fluorescence of cytochrome C with emission at 280 nm on native cytochrome C (solid line), and products 
of refolding at 1:5 (dotted line) 1:10 (short dotted line) and 1:25 (long dotted line). 
Figure 7.9 illustrates that the refold ratio plays a critical role in the outcome of the fold 
quality. At a low refold ratio, sufficient denaturant is still present to cause a large 
increase in fluorescence from excitation at 280 nm from cytochrome C in largely 
unfolded state, whilst at the high ratio of 1:25, there is a decreased signal, which can be 
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attributed from the presence of aggregates absorbing light over these wavelengths. 
(Figure 7.7), whilst at 1:10 the fold can be seen to be very similar to that of the native 
state. 
 
Figure 7.10:Absorbance at 320 nm (dashed line) and anisotropy at 280 nm (solid line) of cytochrome C refolded at 
1:25 in 100 mM Tris 500 mM NaCl conentration. 
The mobility of the protein in Figure 7.10 achieves a rigid state in a shorter time span 
than that of the protein when refolded at a 1:10 ratio. This is also the case for 1:5 
refolding of cytochrome C. Therefore this may be related to the remaining presence of 
urea within the solution. At low concentrations, the urea is rapidly eliminated from the 
structure, allowing the protein to achieve its rigid state rapidly, whilst at much higher 
concentrations of urea, the dilution may only cause a partial unbinding of urea, allowing 
it to adopt a second, partially unfolded state. This state however is clearly aggregation 
prone as can be seen in Figure 7.10. The effect of salt on the aggregation state of the 
protein will be discussed in the concluding chapter, as its effects have been probed in 
more than the work seen in this chapter, however the results seen here may be relate to  
the Hoffmeister effect.[28, 29] 
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Chapter 8 : Conclusions 
Results presented in the chapter on aggregate nucleation indicate that the nucleation 
stage of aggregation in bovine serum albumin has a temperature dependant mechanism. 
Whilst the range of temperatures examined here are above the reported melting point for 
BSA, it is apparent that the protein is not completely unfolded and therefore the extent 
of unfolding will vary with temperature, and appears to have a significant effect on the 
nucleation mechanism. The mid range temperature appears concurrent with mechanisms 
postulated in the literature for other proteins; that the nucleation is a rapid establishment 
of a stable concentration of aggregate. However at the extremes of this range, it appears 
that the mechanisms deviates from this and that there may be clustering of highly 
reactive nuclei at high temperatures (formed from highly unfolded monomer), and 
continual formation of aggregate nuclei at low temperatures (formed from minimally 
unfolded monomer). From this work it is clear that minimal unfolding within the BSA 
monomer is sufficient to cause aggregation to the extent that they form large clustered 
agglomerates. A continuation of this work to yield results across an entire temperature 
range may yield enough data to form a coherent model. 
Analysis presented on the growth of particulate aggregates show that the model of 
monomer addition to the aggregate nuclei appears to be a fitting description of the 
growth process. This differs from the model in the previous chapter in that during this 
growth period, there is a stable concentration of aggregates formed, therefore monomer-
aggregate interactions are more prevalent that monomer-monomer interactions. This 
model is not just suitable for BSA studied in the previous chapter, but appears to be a 
generic form of aggregate growth applicable to proteins with a range of structural 
features. The detailed analysis from the UVLSS technique provides thermodynamic 
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values which appear in agreement with comparable literature values, and that of other 
studies used within this document. There is some apparent discrepancy in the state of 
the BSA molecule when it is aggregation prone. Kratky plots indicate that the protein 
molecule is only partially unfolded for aggregation to occur whilst the UVLSS model 
indicates that the BSA molecule is unfolded at 80 ºC. The UVLSS studies however are 
purely an indication of when aggregation occurs; therefore what is referred to as the 
“unfolded” state is one that is sufficiently unfolded to initiate aggregation, which is not 
necessarily a completely unfolded molecule. Furthermore the technique provides a 
numerical method for examining the efficiency of aggregate preventing additives, and 
also illustrates the mechanism by which the additives prevent aggregation. A prime 
example of such is the ability of Tween 20 to reduce aggregation by reducing the 
collision constant between aggregate prone protein molecules. 
Results presented in the chapter on aggregation during refolding indicate the use of 
fluorescence anisotropy to monitor the molten globule state during refolding of proteins. 
The mobility of fluorescent side chain residues has been shown to be prevalent during 
the refolding stage, with the mobility in existence for up to 30s, with some variance 
between protein species. Most strikingly, there is an obvious relationship between the 
mobility period of the protein and its propensity to aggregate. However, this mobility is 
also a necessary step in order for the protein to achieve its native structure, therefore a 
trade-off exists between achievement of native protein structure and aggregate 
prevalence.  
Furthermore, this body of work has examined the role of salt using a number of these 
techniques, and whilst it appears that the charge shielding properties appear to stabilise 
the protein during hydrophobic collapse at low temperatures, at high concentrations and 
temperatures it exhibits a destabilising effect on the protein, and promotes aggregation. 
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This behaviour can be attributed to the Hofmeister effect, whose mechanism remains 
speculated upon in the literature. The sodium ions increase the solubility of the peptide 
residues; preventing aggregation. This may also reduce the number of successful 
collisions resulting in aggregation, as seen from the decreasing K4 value with increasing 
salt concentration in the UVLSS chapter. However, when presented with a folded 
protein, a sufficient concentration of sodium ions can cause the precipitation of 
hydrophobic groups, resulting in aggregation. This interaction with hydrophobic groups 
can explain the results seen from UVLSS data, where increasing salt concentration 
increases the rate of aggregation. This effect can appear counter-intuitive, and merits 
further investigation into the effects of salts on protein solubility. 
Overall, this work provides insights into the nature of protein aggregation: illustrating 
that nucleation mechanisms are more complex than current literature suggests, 
presenting a technique for examining protein aggregation kinetics and thermodynamics 
,presenting examples of analysis of aggregation preventing additives, and illustrating 
that the mobility of the protein has a direct correlation to its propensity to aggregate, 
whilst also highlighting areas of the research which merit further investigation. 
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Chapter 9 : Future Work 
Below are listed future experiments relating to each section of work, and how the 
knowledge of each area could be expanded: 
a) Aggregate nucleation using neutron scattering (Chapter 5) – Whilst the work 
here provides information on the nucleation of particulate aggregates, it fails to 
probe events on a single protein molecule size scale. Further experiments could 
be performed similar to those here, but at a lower temperature range, thus 
slowing down the nucleation, allowing for better statistics to be collected over 
the small time scales. As has been shown here, the behaviour of the nucleating 
monomers appears to change with temperature, therefore elucidating the 
mechanism of these higher temperature monomers may require a beamline with 
more flux or detector sensitivity than currently exists, and alternatively X-ray 
studies may be better suited. 
b) Aggregation preventing additives studies using UVLSS (Chapter 6) – The work 
in this section paves the way for studies to be performed on all manner of 
aggregation preventing additives to elucidate their effectiveness and method of 
action. A prime example would be to test the use of amino acids as aggregate 
preventing additives which are stated in the literature. 
c) Protein mobility and aggregation (Chapter 7) – In order to compliment the 
mobility work performed here, temperature studies could be performed using 
fluorescence anisotropy to assess the mobility of the protein during heating. In 
addition, single molecule studies such as FRET would provide much greater 
detail of exactly how this mobility is brought about. 
